#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-9	Polygenic	_
1-2	10-14	risk	_
1-3	15-20	score	_
1-4	21-24	for	_
1-5	25-38	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-6	39-42	and	_
1-7	43-53	structural	_
1-8	54-59	brain	_
1-9	60-72	connectivity	_
1-10	73-75	in	_
1-11	76-81	older	_
1-12	82-85	age	_
1-13	86-87	:	_
1-14	88-89	A	_
1-15	90-102	longitudinal	_
1-16	103-113	connectome	_
1-17	114-117	and	_
1-18	118-130	tractography	_
1-19	131-136	study	_
1-20	137-143	Higher	_
1-21	144-153	polygenic	_
1-22	154-158	risk	_
1-23	159-164	score	_
1-24	165-168	for	_
1-25	169-182	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-26	183-184	(	_
1-27	185-191	szPGRS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
1-28	192-193	)	_
1-29	194-197	has	_
1-30	198-202	been	_
1-31	203-213	associated	_
1-32	214-218	with	_
1-33	219-224	lower	_
1-34	225-234	cognitive	_
1-35	235-243	function	_
1-36	244-247	and	_
1-37	248-253	might	_
1-38	254-256	be	_
1-39	257-258	a	_
1-40	259-268	predictor	_
1-41	269-271	of	_
1-42	272-279	decline	_
1-43	280-282	in	_
1-44	283-288	brain	_
1-45	289-298	structure	_
1-46	299-301	in	_
1-47	302-312	apparently	_
1-48	313-320	healthy	_
1-49	321-332	populations	_
1-50	333-334	.	_

2-1	335-346	Age-related	_
2-2	347-355	declines	_
2-3	356-358	in	_
2-4	359-369	structural	_
2-5	370-375	brain	_
2-6	376-397	connectivity—measured	_
2-7	398-403	using	_
2-8	404-409	white	_
2-9	410-416	matter	_
2-10	417-426	diffusion	_
2-11	427-430	MRI	_
2-12	431-435	—are	_
2-13	436-443	evident	_
2-14	444-448	from	_
2-15	449-464	cross-sectional	_
2-16	465-469	data	_
2-17	470-471	.	_

3-1	472-475	Yet	_
3-2	476-477	,	_
3-3	478-480	it	_
3-4	481-488	remains	_
3-5	489-496	unclear	_
3-6	497-500	how	_
3-7	501-506	graph	_
3-8	507-518	theoretical	_
3-9	519-526	metrics	_
3-10	527-529	of	_
3-11	530-533	the	_
3-12	534-544	structural	_
3-13	545-555	connectome	_
3-14	556-562	change	_
3-15	563-567	over	_
3-16	568-572	time	_
3-17	573-574	,	_
3-18	575-578	and	_
3-19	579-586	whether	_
3-20	587-593	szPGRS	_
3-21	594-596	is	_
3-22	597-607	associated	_
3-23	608-612	with	_
3-24	613-624	differences	_
3-25	625-627	in	_
3-26	628-642	ageing-related	_
3-27	643-650	changes	_
3-28	651-653	in	_
3-29	654-659	human	_
3-30	660-665	brain	_
3-31	666-678	connectivity	_
3-32	679-680	.	_

4-1	681-685	Here	_
4-2	686-687	,	_
4-3	688-690	we	_
4-4	691-698	studied	_
4-5	699-700	a	_
4-6	701-706	large	_
4-7	707-708	,	_
4-8	709-719	relatively	_
4-9	720-727	healthy	_
4-10	728-729	,	_
4-11	730-748	same-year-of-birth	_
4-12	749-750	,	_
4-13	751-756	older	_
4-14	757-760	age	_
4-15	761-767	cohort	_
4-16	768-772	over	_
4-17	773-774	a	_
4-18	775-781	period	_
4-19	782-784	of	_
4-20	785-786	3	_
4-21	787-792	years	_
4-22	793-794	(	_
4-23	795-798	age	_
4-24	799-800	∼	_
4-25	801-803	73	_
4-26	804-809	years	_
4-27	810-811	,	_
4-28	812-813	N	_
4-29	814-815	=	_
4-30	816-819	731	_
4-31	820-821	;	_
4-32	822-825	age	_
4-33	826-829	∼76	_
4-34	830-835	years	_
4-35	836-837	,	_
4-36	838-839	N	_
4-37	840-841	=	_
4-38	842-845	488	_
4-39	846-847	)	_
4-40	848-849	.	_

5-1	850-854	From	_
5-2	855-860	their	_
5-3	861-866	brain	_
5-4	867-872	scans	_
5-5	873-875	we	_
5-6	876-883	derived	_
5-7	884-898	tract-averaged	_
5-8	899-909	fractional	_
5-9	910-920	anisotropy	_
5-10	921-922	(	_
5-11	923-925	FA	_
5-12	926-927	)	_
5-13	928-931	and	_
5-14	932-936	mean	_
5-15	937-948	diffusivity	_
5-16	949-950	(	_
5-17	951-953	MD	_
5-18	954-955	)	_
5-19	956-957	,	_
5-20	958-961	and	_
5-21	962-969	network	_
5-22	970-978	topology	_
5-23	979-989	properties	_
5-24	990-991	.	_

6-1	992-994	We	_
6-2	995-1007	investigated	_
6-3	1008-1011	the	_
6-4	1012-1027	cross-sectional	_
6-5	1028-1031	and	_
6-6	1032-1044	longitudinal	_
6-7	1045-1057	associations	_
6-8	1058-1065	between	_
6-9	1066-1071	these	_
6-10	1072-1082	structural	_
6-11	1083-1088	brain	_
6-12	1089-1098	variables	_
6-13	1099-1102	and	_
6-14	1103-1109	szPGRS	_
6-15	1110-1111	.	_

7-1	1112-1118	Higher	_
7-2	1119-1125	szPGRS	_
7-3	1126-1132	showed	_
7-4	1133-1144	significant	_
7-5	1145-1157	associations	_
7-6	1158-1162	with	_
7-7	1163-1175	longitudinal	_
7-8	1176-1185	increases	_
7-9	1186-1188	in	_
7-10	1189-1191	MD	_
7-11	1192-1194	in	_
7-12	1195-1198	the	_
7-13	1199-1207	splenium	_
7-14	1208-1209	(	_
7-15	1210-1211	β	_
7-16	1212-1213	=	_
7-17	1214-1219	0.132	_
7-18	1220-1221	,	_
7-19	1222-1226	pFDR	_
7-20	1227-1228	=	_
7-21	1229-1234	0.040	_
7-22	1235-1236	)	_
7-23	1237-1238	,	_
7-24	1239-1246	arcuate	_
7-25	1247-1248	(	_
7-26	1249-1250	β	_
7-27	1251-1252	=	_
7-28	1253-1258	0.291	_
7-29	1259-1260	,	_
7-30	1261-1265	pFDR	_
7-31	1266-1267	=	_
7-32	1268-1273	0.040	_
7-33	1274-1275	)	_
7-34	1276-1277	,	_
7-35	1278-1286	anterior	_
7-36	1287-1295	thalamic	_
7-37	1296-1306	radiations	_
7-38	1307-1308	(	_
7-39	1309-1310	β	_
7-40	1311-1312	=	_
7-41	1313-1318	0.215	_
7-42	1319-1320	,	_
7-43	1321-1325	pFDR	_
7-44	1326-1327	=	_
7-45	1328-1333	0.040	_
7-46	1334-1335	)	_
7-47	1336-1339	and	_
7-48	1340-1348	cingulum	_
7-49	1349-1350	(	_
7-50	1351-1352	β	_
7-51	1353-1354	=	_
7-52	1355-1360	0.165	_
7-53	1361-1362	,	_
7-54	1363-1367	pFDR	_
7-55	1368-1369	=	_
7-56	1370-1375	0.040	_
7-57	1376-1377	)	_
7-58	1378-1379	.	_

8-1	1380-1391	Significant	_
8-2	1392-1400	declines	_
8-3	1401-1405	over	_
8-4	1406-1410	time	_
8-5	1411-1415	were	_
8-6	1416-1424	observed	_
8-7	1425-1427	in	_
8-8	1428-1433	graph	_
8-9	1434-1440	theory	_
8-10	1441-1448	metrics	_
8-11	1449-1452	for	_
8-12	1453-1464	FA-weighted	_
8-13	1465-1473	networks	_
8-14	1474-1475	,	_
8-15	1476-1480	such	_
8-16	1481-1483	as	_
8-17	1484-1488	mean	_
8-18	1489-1493	edge	_
8-19	1494-1500	weight	_
8-20	1501-1502	(	_
8-21	1503-1504	β	_
8-22	1505-1506	=	_
8-23	1507-1513	−0.039	_
8-24	1514-1515	,	_
8-25	1516-1520	pFDR	_
8-26	1521-1522	=	_
8-27	1523-1528	0.048	_
8-28	1529-1530	)	_
8-29	1531-1534	and	_
8-30	1535-1543	strength	_
8-31	1544-1545	(	_
8-32	1546-1547	β	_
8-33	1548-1549	=	_
8-34	1550-1556	−0.027	_
8-35	1557-1558	,	_
8-36	1559-1563	pFDR	_
8-37	1564-1565	=	_
8-38	1566-1571	0.048	_
8-39	1572-1573	)	_
8-40	1574-1575	.	_

9-1	1576-1578	No	_
9-2	1579-1590	significant	_
9-3	1591-1603	associations	_
9-4	1604-1608	were	_
9-5	1609-1614	found	_
9-6	1615-1622	between	_
9-7	1623-1629	szPGRS	_
9-8	1630-1633	and	_
9-9	1634-1639	graph	_
9-10	1640-1646	theory	_
9-11	1647-1654	metrics	_
9-12	1655-1656	.	_

10-1	1657-1662	These	_
10-2	1663-1670	results	_
10-3	1671-1674	are	_
10-4	1675-1685	consistent	_
10-5	1686-1690	with	_
10-6	1691-1694	the	_
10-7	1695-1705	hypothesis	_
10-8	1706-1710	that	_
10-9	1711-1717	szPGRS	_
10-10	1718-1725	confers	_
10-11	1726-1730	risk	_
10-12	1731-1734	for	_
10-13	1735-1749	ageing-related	_
10-14	1750-1761	degradation	_
10-15	1762-1764	of	_
10-16	1765-1769	some	_
10-17	1770-1777	aspects	_
10-18	1778-1780	of	_
10-19	1781-1791	structural	_
10-20	1792-1804	connectivity	_
10-21	1805-1806	.	_

11-1	1807-1817	Highlights	_
11-2	1818-1823	Large	_
11-3	1824-1836	longitudinal	_
11-4	1837-1840	MRI	_
11-5	1841-1846	study	_
11-6	1847-1849	of	_
11-7	1850-1855	brain	_
11-8	1856-1865	structure	_
11-9	1866-1868	in	_
11-10	1869-1875	narrow	_
11-11	1876-1879	age	_
11-12	1880-1885	range	_
11-13	1886-1891	older	_
11-14	1892-1895	age	_
11-15	1896-1902	cohort	_
11-16	1903-1904	.	_

12-1	1905-1917	Longitudinal	_
12-2	1918-1925	changes	_
12-3	1926-1931	occur	_
12-4	1932-1934	in	_
12-5	1935-1940	white	_
12-6	1941-1947	matter	_
12-7	1948-1954	tracts	_
12-8	1955-1959	from	_
12-9	1960-1963	age	_
12-10	1964-1966	73	_
12-11	1967-1969	to	_
12-12	1970-1972	76	_
12-13	1973-1974	.	_

13-1	1975-1980	Graph	_
13-2	1981-1987	theory	_
13-3	1988-1995	metrics	_
13-4	1996-2000	also	_
13-5	2001-2007	showed	_
13-6	2008-2020	longitudinal	_
13-7	2021-2031	reductions	_
13-8	2032-2036	over	_
13-9	2037-2041	that	_
13-10	2042-2048	period	_
13-11	2049-2050	.	_

14-1	2051-2066	Microstructural	_
14-2	2067-2074	changes	_
14-3	2075-2077	in	_
14-4	2078-2083	white	_
14-5	2084-2090	matter	_
14-6	2091-2100	correlate	_
14-7	2101-2105	with	_
14-8	2106-2113	changes	_
14-9	2114-2116	in	_
14-10	2117-2122	brain	_
14-11	2123-2124	’	_
14-12	2125-2126	s	_
14-13	2127-2134	network	_
14-14	2135-2136	.	_

15-1	2137-2143	Higher	_
15-2	2144-2151	genetic	_
15-3	2152-2156	risk	_
15-4	2157-2160	for	_
15-5	2161-2174	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-6	2175-2177	is	_
15-7	2178-2188	associated	_
15-8	2189-2193	with	_
15-9	2194-2201	changes	_
15-10	2202-2204	in	_
15-11	2205-2210	brain	_
15-12	2211-2220	structure	_
15-13	2221-2222	.	_

16-1	2223-2230	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
16-2	2231-2243	Participants	_
16-3	2244-2247	The	_
16-4	2248-2255	LBC1936	_
16-5	2256-2261	study	_
16-6	2262-2270	provides	_
16-7	2271-2283	longitudinal	_
16-8	2284-2288	data	_
16-9	2289-2291	on	_
16-10	2292-2301	cognitive	_
16-11	2302-2305	and	_
16-12	2306-2311	brain	_
16-13	2312-2318	ageing	_
16-14	2319-2320	.	_

17-1	2321-2324	The	_
17-2	2325-2331	cohort	_
17-3	2332-2341	comprises	_
17-4	2342-2354	participants	_
17-5	2355-2357	of	_
17-6	2358-2361	the	_
17-7	2362-2370	Scottish	_
17-8	2371-2377	Mental	_
17-9	2378-2384	Survey	_
17-10	2385-2387	of	_
17-11	2388-2392	1947	_
17-12	2393-2394	(	_
17-13	2395-2398	SMS	_
17-14	2399-2403	1947	_
17-15	2404-2405	,	_
17-16	2406-2407	n	_
17-17	2408-2409	=	_
17-18	2410-2416	70,805	_
17-19	2417-2418	)	_
17-20	2419-2421	in	_
17-21	2422-2427	which	_
17-22	2428-2432	most	_
17-23	2433-2441	Scottish	_
17-24	2442-2456	schoolchildren	_
17-25	2457-2461	born	_
17-26	2462-2464	in	_
17-27	2465-2469	1936	_
17-28	2470-2473	sat	_
17-29	2474-2477	the	_
17-30	2478-2483	Moray	_
17-31	2484-2489	House	_
17-32	2490-2494	Test	_
17-33	2495-2501	Number	_
17-34	2502-2504	12	_
17-35	2505-2507	at	_
17-36	2508-2511	∼11	_
17-37	2512-2517	years	_
17-38	2518-2520	of	_
17-39	2521-2524	age	_
17-40	2525-2526	.	_

18-1	2527-2531	Most	_
18-2	2532-2544	participants	_
18-3	2545-2552	resided	_
18-4	2553-2555	in	_
18-5	2556-2559	the	_
18-6	2560-2569	Edinburgh	_
18-7	2570-2573	and	_
18-8	2574-2581	Lothian	_
18-9	2582-2589	regions	_
18-10	2590-2592	of	_
18-11	2593-2601	Scotland	_
18-12	2602-2604	at	_
18-13	2605-2616	recruitment	_
18-14	2617-2620	age	_
18-15	2621-2624	∼70	_
18-16	2625-2630	years	_
18-17	2631-2632	.	_

19-1	2633-2636	The	_
19-2	2637-2643	sample	_
19-3	2644-2647	has	_
19-4	2648-2652	been	_
19-5	2653-2663	repeatedly	_
19-6	2664-2670	tested	_
19-7	2671-2673	in	_
19-8	2674-2679	later	_
19-9	2680-2684	life	_
19-10	2685-2689	with	_
19-11	2690-2702	participants	_
19-12	2703-2713	undergoing	_
19-13	2714-2722	detailed	_
19-14	2723-2730	medical	_
19-15	2731-2732	,	_
19-16	2733-2741	physical	_
19-17	2742-2743	,	_
19-18	2744-2747	and	_
19-19	2748-2761	psycho-social	_
19-20	2762-2773	assessments	_
19-21	2774-2775	,	_
19-22	2776-2785	including	_
19-23	2786-2787	a	_
19-24	2788-2793	brain	_
19-25	2794-2797	MRI	_
19-26	2798-2809	examination	_
19-27	2810-2811	.	_

20-1	2812-2815	The	_
20-2	2816-2821	first	_
20-3	2822-2829	testing	_
20-4	2830-2834	wave	_
20-5	2835-2839	took	_
20-6	2840-2845	place	_
20-7	2846-2848	at	_
20-8	2849-2850	a	_
20-9	2851-2855	mean	_
20-10	2856-2859	age	_
20-11	2860-2862	of	_
20-12	2863-2868	69.53	_
20-13	2869-2874	years	_
20-14	2875-2876	(	_
20-15	2877-2879	SD	_
20-16	2880-2881	,	_
20-17	2882-2886	0.83	_
20-18	2887-2892	years	_
20-19	2893-2894	)	_
20-20	2895-2897	in	_
20-21	2898-2907	2004–2007	_
20-22	2908-2909	(	_
20-23	2910-2911	n	_
20-24	2912-2913	=	_
20-25	2914-2919	1,091	_
20-26	2920-2921	,	_
20-27	2922-2925	543	_
20-28	2926-2933	females	_
20-29	2934-2935	)	_
20-30	2936-2937	;	_
20-31	2938-2941	the	_
20-32	2942-2948	second	_
20-33	2949-2956	testing	_
20-34	2957-2961	wave	_
20-35	2962-2966	took	_
20-36	2967-2972	place	_
20-37	2973-2975	at	_
20-38	2976-2977	a	_
20-39	2978-2982	mean	_
20-40	2983-2986	age	_
20-41	2987-2989	of	_
20-42	2990-2995	72.49	_
20-43	2996-3001	years	_
20-44	3002-3003	(	_
20-45	3004-3006	SD	_
20-46	3007-3008	,	_
20-47	3009-3013	0.71	_
20-48	3014-3019	years	_
20-49	3020-3021	)	_
20-50	3022-3024	in	_
20-51	3025-3034	2007–2010	_
20-52	3035-3036	(	_
20-53	3037-3038	n	_
20-54	3039-3040	=	_
20-55	3041-3044	866	_
20-56	3045-3046	,	_
20-57	3047-3050	418	_
20-58	3051-3058	females	_
20-59	3059-3060	)	_
20-60	3061-3062	;	_
20-61	3063-3066	and	_
20-62	3067-3070	the	_
20-63	3071-3076	third	_
20-64	3077-3084	testing	_
20-65	3085-3089	wave	_
20-66	3090-3094	took	_
20-67	3095-3100	place	_
20-68	3101-3103	at	_
20-69	3104-3105	a	_
20-70	3106-3110	mean	_
20-71	3111-3114	age	_
20-72	3115-3117	of	_
20-73	3118-3123	76.25	_
20-74	3124-3129	years	_
20-75	3130-3131	(	_
20-76	3132-3134	SD	_
20-77	3135-3136	,	_
20-78	3137-3141	0.68	_
20-79	3142-3147	years	_
20-80	3148-3149	)	_
20-81	3150-3152	in	_
20-82	3153-3162	2011–2014	_
20-83	3163-3164	(	_
20-84	3165-3166	n	_
20-85	3167-3168	=	_
20-86	3169-3172	697	_
20-87	3173-3174	,	_
20-88	3175-3178	337	_
20-89	3179-3186	females	_
20-90	3187-3188	)	_
20-91	3189-3190	.	_

21-1	3191-3194	The	_
21-2	3195-3199	data	_
21-3	3200-3202	in	_
21-4	3203-3206	the	_
21-5	3207-3214	present	_
21-6	3215-3221	report	_
21-7	3222-3226	come	_
21-8	3227-3231	from	_
21-9	3232-3235	the	_
21-10	3236-3242	second	_
21-11	3243-3246	and	_
21-12	3247-3252	third	_
21-13	3253-3258	waves	_
21-14	3259-3261	of	_
21-15	3262-3265	the	_
21-16	3266-3271	study	_
21-17	3272-3274	at	_
21-18	3275-3280	which	_
21-19	3281-3287	points	_
21-20	3288-3298	structural	_
21-21	3299-3304	brain	_
21-22	3305-3312	imaging	_
21-23	3313-3316	was	_
21-24	3317-3326	performed	_
21-25	3327-3328	.	_

22-1	3329-3330	A	_
22-2	3331-3336	total	_
22-3	3337-3339	of	_
22-4	3340-3343	731	_
22-5	3344-3356	participants	_
22-6	3357-3358	(	_
22-7	3359-3362	343	_
22-8	3363-3370	females	_
22-9	3371-3372	)	_
22-10	3373-3379	agreed	_
22-11	3380-3382	to	_
22-12	3383-3390	undergo	_
22-13	3391-3396	brain	_
22-14	3397-3404	imaging	_
22-15	3405-3407	at	_
22-16	3408-3409	a	_
22-17	3410-3414	mean	_
22-18	3415-3418	age	_
22-19	3419-3421	of	_
22-20	3422-3427	72.68	_
22-21	3428-3433	years	_
22-22	3434-3435	(	_
22-23	3436-3438	SD	_
22-24	3439-3440	,	_
22-25	3441-3445	0.72	_
22-26	3446-3451	years	_
22-27	3452-3453	)	_
22-28	3454-3455	,	_
22-29	3456-3459	and	_
22-30	3460-3463	488	_
22-31	3464-3465	(	_
22-32	3466-3469	228	_
22-33	3470-3477	females	_
22-34	3478-3479	)	_
22-35	3480-3482	at	_
22-36	3483-3484	a	_
22-37	3485-3489	mean	_
22-38	3490-3493	age	_
22-39	3494-3496	of	_
22-40	3497-3502	76.38	_
22-41	3503-3508	years	_
22-42	3509-3510	(	_
22-43	3511-3513	SD	_
22-44	3514-3515	,	_
22-45	3516-3520	0.65	_
22-46	3521-3526	years	_
22-47	3527-3528	)	_
22-48	3529-3530	,	_
22-49	3531-3535	none	_
22-50	3536-3538	of	_
22-51	3539-3543	whom	_
22-52	3544-3548	were	_
22-53	3549-3554	known	_
22-54	3555-3557	to	_
22-55	3558-3562	have	_
22-56	3563-3576	schizophrenia	_
22-57	3577-3578	.	_

23-1	3579-3583	Only	_
23-2	3584-3587	one	_
23-3	3588-3599	participant	_
23-4	3600-3603	was	_
23-5	3604-3613	diagnosed	_
23-6	3614-3618	with	_
23-7	3619-3626	bipolar	_
23-8	3627-3635	disorder	_
23-9	3636-3637	.	_

24-1	3638-3645	However	_
24-2	3646-3647	,	_
24-3	3648-3651	the	_
24-4	3652-3656	data	_
24-5	3657-3666	indicated	_
24-6	3667-3671	that	_
24-7	3672-3676	this	_
24-8	3677-3688	participant	_
24-9	3689-3692	was	_
24-10	3693-3696	not	_
24-11	3697-3699	an	_
24-12	3700-3707	outlier	_
24-13	3708-3709	(	_
24-14	3710-3714	±2.5	_
24-15	3715-3717	SD	_
24-16	3718-3721	for	_
24-17	3722-3725	all	_
24-18	3726-3731	brain	_
24-19	3732-3739	imaging	_
24-20	3740-3748	measures	_
24-21	3749-3750	)	_
24-22	3751-3754	and	_
24-23	3755-3764	therefore	_
24-24	3765-3766	,	_
24-25	3767-3771	this	_
24-26	3772-3779	subject	_
24-27	3780-3783	was	_
24-28	3784-3787	not	_
24-29	3788-3796	excluded	_
24-30	3797-3801	from	_
24-31	3802-3805	the	_
24-32	3806-3814	analysis	_
24-33	3815-3816	.	_

25-1	3817-3820	The	_
25-2	3821-3826	study	_
25-3	3827-3830	was	_
25-4	3831-3839	approved	_
25-5	3840-3842	by	_
25-6	3843-3846	the	_
25-7	3847-3859	Multi-Centre	_
25-8	3860-3868	Research	_
25-9	3869-3875	Ethics	_
25-10	3876-3885	Committee	_
25-11	3886-3889	for	_
25-12	3890-3898	Scotland	_
25-13	3899-3900	(	_
25-14	3901-3913	MREC/01/0/56	_
25-15	3914-3915	)	_
25-16	3916-3917	,	_
25-17	3918-3921	the	_
25-18	3922-3929	Lothian	_
25-19	3930-3938	Research	_
25-20	3939-3945	Ethics	_
25-21	3946-3955	Committee	_
25-22	3956-3957	(	_
25-23	3958-3972	LREC/2003/2/29	_
25-24	3973-3974	)	_
25-25	3975-3978	and	_
25-26	3979-3982	the	_
25-27	3983-3991	Scotland	_
25-28	3992-3993	A	_
25-29	3994-4002	Research	_
25-30	4003-4009	Ethics	_
25-31	4010-4019	Committee	_
25-32	4020-4021	(	_
25-33	4022-4033	07/MRE00/58	_
25-34	4034-4035	)	_
25-35	4036-4037	.	_

26-1	4038-4041	All	_
26-2	4042-4054	participants	_
26-3	4055-4064	completed	_
26-4	4065-4072	written	_
26-5	4073-4081	informed	_
26-6	4082-4089	consent	_
26-7	4090-4095	forms	_
26-8	4096-4102	before	_
26-9	4103-4106	any	_
26-10	4107-4116	cognitive	_
26-11	4117-4118	,	_
26-12	4119-4122	MRI	_
26-13	4123-4124	,	_
26-14	4125-4127	or	_
26-15	4128-4133	other	_
26-16	4134-4146	measurements	_
26-17	4147-4151	were	_
26-18	4152-4157	taken	_
26-19	4158-4159	.	_

27-1	4160-4164	Scan	_
27-2	4165-4176	acquisition	_
27-3	4177-4180	All	_
27-4	4181-4191	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
27-5	4192-4195	and	_
27-6	4196-4205	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
27-7	4206-4209	MRI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
27-8	4210-4214	data	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
27-9	4215-4219	were	_
27-10	4220-4228	acquired	_
27-11	4229-4234	using	_
27-12	4235-4236	a	_
27-13	4237-4239	GE	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-14	4240-4245	Signa	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-15	4246-4253	Horizon	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-16	4254-4257	HDx	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-17	4258-4261	1.5	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-18	4262-4263	T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-19	4264-4272	clinical	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-20	4273-4280	scanner	http://maven.renci.org/NeuroBridge/neurobridge#2Level
27-21	4281-4282	(	_
27-22	4283-4290	General	_
27-23	4291-4299	Electric	_
27-24	4300-4301	,	_
27-25	4302-4311	Milwaukee	_
27-26	4312-4313	,	_
27-27	4314-4316	WI	_
27-28	4317-4318	,	_
27-29	4319-4322	USA	_
27-30	4323-4324	)	_
27-31	4325-4330	using	_
27-32	4331-4332	a	_
27-33	4333-4347	self-shielding	_
27-34	4348-4356	gradient	_
27-35	4357-4360	set	_
27-36	4361-4365	with	_
27-37	4366-4373	maximum	_
27-38	4374-4382	gradient	_
27-39	4383-4391	strength	_
27-40	4392-4394	of	_
27-41	4395-4397	33	_
27-42	4398-4400	mT	_
27-43	4401-4404	m−1	_
27-44	4405-4406	,	_
27-45	4407-4410	and	_
27-46	4411-4424	eight-channel	_
27-47	4425-4429	head	_
27-48	4430-4435	array	_
27-49	4436-4440	coil	_
27-50	4441-4442	.	_

28-1	4443-4461	Diffusion-weighted	_
28-2	4462-4473	echo-planar	_
28-3	4474-4481	volumes	_
28-4	4482-4483	(	_
28-5	4484-4485	b	_
28-6	4486-4487	=	_
28-7	4488-4492	1000	_
28-8	4493-4494	s	_
28-9	4495-4499	mm−2	_
28-10	4500-4501	)	_
28-11	4502-4506	were	_
28-12	4507-4515	acquired	_
28-13	4516-4518	in	_
28-14	4519-4521	64	_
28-15	4522-4535	non-collinear	_
28-16	4536-4546	directions	_
28-17	4547-4548	,	_
28-18	4549-4554	along	_
28-19	4555-4559	with	_
28-20	4560-4565	seven	_
28-21	4566-4577	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
28-22	4578-4585	volumes	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
28-23	4586-4587	(	_
28-24	4588-4589	b	_
28-25	4590-4591	=	_
28-26	4592-4593	0	_
28-27	4594-4595	s	_
28-28	4596-4600	mm−2	_
28-29	4601-4602	)	_
28-30	4603-4604	.	_

29-1	4605-4609	Each	_
29-2	4610-4616	volume	_
29-3	4617-4626	comprised	_
29-4	4627-4638	seventy-two	_
29-5	4639-4649	contiguous	_
29-6	4650-4655	axial	_
29-7	4656-4666	2-mm-thick	_
29-8	4667-4673	slices	_
29-9	4674-4682	acquired	_
29-10	4683-4687	with	_
29-11	4688-4689	2	_
29-12	4690-4691	×	_
29-13	4692-4693	2	_
29-14	4694-4696	mm	_
29-15	4697-4705	in-plane	_
29-16	4706-4716	resolution	_
29-17	4717-4718	.	_

30-1	4719-4729	Repetition	_
30-2	4730-4733	and	_
30-3	4734-4738	echo	_
30-4	4739-4744	times	_
30-5	4745-4749	were	_
30-6	4750-4754	16.5	_
30-7	4755-4756	s	_
30-8	4757-4760	and	_
30-9	4761-4765	95.5	_
30-10	4766-4767	m	_
30-11	4768-4769	s	_
30-12	4770-4782	respectively	_
30-13	4783-4784	.	_

31-1	4785-4786	A	_
31-2	4787-4789	3D	_
31-3	4790-4801	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
31-4	4802-4811	inversion	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
31-5	4812-4829	recovery-prepared	_
31-6	4830-4834	fast	_
31-7	4835-4842	spoiled	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-8	4843-4856	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-9	4857-4858	(	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-10	4859-4864	FSPGR	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-11	4865-4866	)	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
31-12	4867-4873	volume	_
31-13	4874-4877	was	_
31-14	4878-4882	also	_
31-15	4883-4891	acquired	_
31-16	4892-4894	in	_
31-17	4895-4898	the	_
31-18	4899-4906	coronal	_
31-19	4907-4912	plane	_
31-20	4913-4917	with	_
31-21	4918-4921	160	_
31-22	4922-4932	contiguous	_
31-23	4933-4939	slices	_
31-24	4940-4943	and	_
31-25	4944-4947	1.3	_
31-26	4948-4951	mm3	_
31-27	4952-4957	voxel	_
31-28	4958-4968	dimensions	_
31-29	4969-4970	.	_

32-1	4971-4975	Full	_
32-2	4976-4983	details	_
32-3	4984-4986	of	_
32-4	4987-4990	the	_
32-5	4991-4998	imaging	_
32-6	4999-5007	protocol	_
32-7	5008-5011	are	_
32-8	5012-5021	available	_
32-9	5022-5023	.	_

33-1	5024-5027	The	_
33-2	5028-5035	scanner	_
33-3	5036-5045	underwent	_
33-4	5046-5047	a	_
33-5	5048-5053	major	_
33-6	5054-5061	upgrade	_
33-7	5062-5066	just	_
33-8	5067-5072	prior	_
33-9	5073-5075	to	_
33-10	5076-5079	the	_
33-11	5080-5085	first	_
33-12	5086-5090	wave	_
33-13	5091-5093	of	_
33-14	5094-5101	imaging	_
33-15	5102-5105	and	_
33-16	5106-5109	was	_
33-17	5110-5119	regulated	_
33-18	5120-5132	continuously	_
33-19	5133-5139	within	_
33-20	5140-5141	a	_
33-21	5142-5147	tight	_
33-22	5148-5155	quality	_
33-23	5156-5163	control	_
33-24	5164-5175	environment	_
33-25	5176-5182	across	_
33-26	5183-5186	the	_
33-27	5187-5195	duration	_
33-28	5196-5198	of	_
33-29	5199-5202	the	_
33-30	5203-5208	study	_
33-31	5209-5210	;	_
33-32	5211-5214	all	_
33-33	5215-5220	scans	_
33-34	5221-5225	were	_
33-35	5226-5234	acquired	_
33-36	5235-5239	with	_
33-37	5240-5243	the	_
33-38	5244-5248	same	_
33-39	5249-5256	imaging	_
33-40	5257-5265	protocol	_
33-41	5266-5269	and	_
33-42	5270-5277	scanner	_
33-43	5278-5286	software	_
33-44	5287-5295	platform	_
33-45	5296-5306	throughout	_
33-46	5307-5308	.	_

34-1	5309-5314	Image	_
34-2	5315-5325	processing	_
34-3	5326-5330	Each	_
34-4	5331-5333	3D	http://maven.renci.org/NeuroBridge/neurobridge#Thing
34-5	5334-5345	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-6	5346-5351	FSPGR	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-7	5352-5358	volume	_
34-8	5359-5362	was	_
34-9	5363-5374	parcellated	_
34-10	5375-5379	into	_
34-11	5380-5382	85	_
34-12	5383-5391	cortical	_
34-13	5392-5411	regions-of-interest	_
34-14	5412-5413	(	_
34-15	5414-5417	ROI	_
34-16	5418-5419	)	_
34-17	5420-5425	using	_
34-18	5426-5436	FreeSurfer	_
34-19	5437-5438	(	_
34-20	5439-5443	http	_
34-21	5444-5445	:	_
34-22	5446-5474	//surfer.nmr.mgh.harvard.edu	_
34-23	5475-5476	)	_
34-24	5477-5478	,	_
34-25	5479-5484	which	_
34-26	5485-5494	comprised	_
34-27	5495-5497	34	_
34-28	5498-5506	cortical	_
34-29	5507-5511	ROIs	_
34-30	5512-5515	and	_
34-31	5516-5521	eight	_
34-32	5522-5534	sub-cortical	_
34-33	5535-5539	ROIs	_
34-34	5540-5543	per	_
34-35	5544-5554	hemisphere	_
34-36	5555-5556	,	_
34-37	5557-5561	plus	_
34-38	5562-5565	the	_
34-39	5566-5575	brainstem	_
34-40	5576-5577	.	_

35-1	5578-5591	Segmentations	_
35-2	5592-5596	were	_
35-3	5597-5605	visually	_
35-4	5606-5613	checked	_
35-5	5614-5615	,	_
35-6	5616-5620	then	_
35-7	5621-5625	used	_
35-8	5626-5628	to	_
35-9	5629-5638	construct	_
35-10	5639-5643	grey	_
35-11	5644-5647	and	_
35-12	5648-5653	white	_
35-13	5654-5660	matter	_
35-14	5661-5666	masks	_
35-15	5667-5670	for	_
35-16	5671-5674	use	_
35-17	5675-5677	in	_
35-18	5678-5685	network	_
35-19	5686-5698	construction	_
35-20	5699-5702	and	_
35-21	5703-5705	to	_
35-22	5706-5715	constrain	_
35-23	5716-5719	the	_
35-24	5720-5732	tractography	_
35-25	5733-5739	output	_
35-26	5740-5742	as	_
35-27	5743-5752	described	_
35-28	5753-5758	below	_
35-29	5759-5760	.	_

36-1	5761-5766	Using	_
36-2	5767-5772	tools	_
36-3	5773-5781	provided	_
36-4	5782-5784	by	_
36-5	5785-5788	the	_
36-6	5789-5792	FDT	_
36-7	5793-5800	package	_
36-8	5801-5803	in	_
36-9	5804-5807	FSL	_
36-10	5808-5809	(	_
36-11	5810-5814	http	_
36-12	5815-5816	:	_
36-13	5817-5841	//fsl.fmrib.ox.ac.uk/fsl	_
36-14	5842-5843	)	_
36-15	5844-5845	,	_
36-16	5846-5849	the	_
36-17	5850-5859	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
36-18	5860-5863	MRI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
36-19	5864-5868	data	_
36-20	5869-5873	were	_
36-21	5874-5887	pre-processed	_
36-22	5888-5890	to	_
36-23	5891-5897	reduce	_
36-24	5898-5908	systematic	_
36-25	5909-5916	imaging	_
36-26	5917-5928	distortions	_
36-27	5929-5932	and	_
36-28	5933-5937	bulk	_
36-29	5938-5945	subject	_
36-30	5946-5952	motion	_
36-31	5953-5962	artefacts	_
36-32	5963-5965	by	_
36-33	5966-5971	afﬁne	_
36-34	5972-5984	registration	_
36-35	5985-5987	of	_
36-36	5988-5991	all	_
36-37	5992-6002	subsequent	_
36-38	6003-6005	EP	_
36-39	6006-6013	volumes	_
36-40	6014-6016	to	_
36-41	6017-6020	the	_
36-42	6021-6025	ﬁrst	_
36-43	6026-6037	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
36-44	6038-6040	EP	_
36-45	6041-6047	volume	_
36-46	6048-6049	.	_

37-1	6050-6055	Skull	_
37-2	6056-6065	stripping	_
37-3	6066-6069	and	_
37-4	6070-6075	brain	_
37-5	6076-6086	extraction	_
37-6	6087-6091	were	_
37-7	6092-6101	performed	_
37-8	6102-6104	on	_
37-9	6105-6108	the	_
37-10	6109-6119	registered	_
37-11	6120-6131	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
37-12	6132-6134	EP	_
37-13	6135-6142	volumes	_
37-14	6143-6146	and	_
37-15	6147-6154	applied	_
37-16	6155-6157	to	_
37-17	6158-6161	the	_
37-18	6162-6166	mean	_
37-19	6167-6189	diffusivity/fractional	_
37-20	6190-6200	anisotropy	_
37-21	6201-6202	(	_
37-22	6203-6208	MD/FA	_
37-23	6209-6210	)	_
37-24	6211-6218	volumes	_
37-25	6219-6229	calculated	_
37-26	6230-6232	by	_
37-27	6233-6239	DTIFIT	_
37-28	6240-6242	in	_
37-29	6243-6247	each	_
37-30	6248-6255	subject	_
37-31	6256-6257	.	_

38-1	6258-6261	The	_
38-2	6262-6277	neuroanatomical	_
38-3	6278-6282	ROIs	_
38-4	6283-6293	determined	_
38-5	6294-6296	by	_
38-6	6297-6307	FreeSurfer	_
38-7	6308-6312	were	_
38-8	6313-6317	then	_
38-9	6318-6325	aligned	_
38-10	6326-6330	from	_
38-11	6331-6333	3D	_
38-12	6334-6345	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-13	6346-6352	volume	_
38-14	6353-6355	to	_
38-15	6356-6365	diffusion	_
38-16	6366-6371	space	_
38-17	6372-6377	using	_
38-18	6378-6379	a	_
38-19	6380-6391	cross-modal	_
38-20	6392-6401	nonlinear	_
38-21	6402-6414	registration	_
38-22	6415-6421	method	_
38-23	6422-6423	.	_

39-1	6424-6426	As	_
39-2	6427-6428	a	_
39-3	6429-6433	ﬁrst	_
39-4	6434-6438	step	_
39-5	6439-6440	,	_
39-6	6441-6447	linear	_
39-7	6448-6460	registration	_
39-8	6461-6464	was	_
39-9	6465-6469	used	_
39-10	6470-6472	to	_
39-11	6473-6483	initialize	_
39-12	6484-6487	the	_
39-13	6488-6497	alignment	_
39-14	6498-6500	of	_
39-15	6501-6505	each	_
39-16	6506-6521	brain-extracted	_
39-17	6522-6524	FA	_
39-18	6525-6531	volume	_
39-19	6532-6534	to	_
39-20	6535-6538	the	_
39-21	6539-6552	corresponding	_
39-22	6553-6563	FreeSurfer	_
39-23	6564-6573	extracted	_
39-24	6574-6576	3D	_
39-25	6577-6588	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
39-26	6589-6594	brain	_
39-27	6595-6601	volume	_
39-28	6602-6607	using	_
39-29	6608-6609	a	_
39-30	6610-6616	mutual	_
39-31	6617-6628	information	_
39-32	6629-6633	cost	_
39-33	6634-6642	function	_
39-34	6643-6646	and	_
39-35	6647-6649	an	_
39-36	6650-6655	afﬁne	_
39-37	6656-6665	transform	_
39-38	6666-6670	with	_
39-39	6671-6673	12	_
39-40	6674-6681	degrees	_
39-41	6682-6684	of	_
39-42	6685-6692	freedom	_
39-43	6693-6694	.	_

40-1	6695-6704	Following	_
40-2	6705-6709	this	_
40-3	6710-6724	initialization	_
40-4	6725-6726	,	_
40-5	6727-6728	a	_
40-6	6729-6738	nonlinear	_
40-7	6739-6750	deformation	_
40-8	6751-6755	ﬁeld	_
40-9	6756-6761	based	_
40-10	6762-6768	method	_
40-11	6769-6770	(	_
40-12	6771-6776	FNIRT	_
40-13	6777-6778	)	_
40-14	6779-6782	was	_
40-15	6783-6787	used	_
40-16	6788-6790	to	_
40-17	6791-6796	reﬁne	_
40-18	6797-6802	local	_
40-19	6803-6812	alignment	_
40-20	6813-6814	.	_

41-1	6815-6825	FreeSurfer	_
41-2	6826-6839	segmentations	_
41-3	6840-6843	and	_
41-4	6844-6854	anatomical	_
41-5	6855-6861	labels	_
41-6	6862-6866	were	_
41-7	6867-6871	then	_
41-8	6872-6879	aligned	_
41-9	6880-6882	to	_
41-10	6883-6892	diffusion	_
41-11	6893-6898	space	_
41-12	6899-6904	using	_
41-13	6905-6912	nearest	_
41-14	6913-6922	neighbour	_
41-15	6923-6936	interpolation	_
41-16	6937-6938	.	_

42-1	6939-6951	Tractography	_
42-2	6952-6963	Whole-brain	_
42-3	6964-6977	probabilistic	_
42-4	6978-6990	tractography	_
42-5	6991-6994	was	_
42-6	6995-7004	performed	_
42-7	7005-7010	using	_
42-8	7011-7014	FSL	_
42-9	7015-7017	's	_
42-10	7018-7037	BedpostX/ProbTrackX	_
42-11	7038-7047	algorithm	_
42-12	7048-7049	.	_

43-1	7050-7061	Probability	_
43-2	7062-7069	density	_
43-3	7070-7079	functions	_
43-4	7080-7081	,	_
43-5	7082-7087	which	_
43-6	7088-7096	describe	_
43-7	7097-7100	the	_
43-8	7101-7112	uncertainty	_
43-9	7113-7115	in	_
43-10	7116-7119	the	_
43-11	7120-7129	principal	_
43-12	7130-7140	directions	_
43-13	7141-7143	of	_
43-14	7144-7149	water	_
43-15	7150-7159	diffusion	_
43-16	7160-7161	,	_
43-17	7162-7166	were	_
43-18	7167-7175	computed	_
43-19	7176-7181	using	_
43-20	7182-7183	a	_
43-21	7184-7192	two-ﬁbre	_
43-22	7193-7198	model	_
43-23	7199-7202	per	_
43-24	7203-7208	voxel	_
43-25	7209-7210	.	_

44-1	7211-7217	Twelve	_
44-2	7218-7223	major	_
44-3	7224-7230	tracts	_
44-4	7231-7235	were	_
44-5	7236-7246	identified	_
44-6	7247-7249	in	_
44-7	7250-7254	each	_
44-8	7255-7266	participant	_
44-9	7267-7272	using	_
44-10	7273-7286	probabilistic	_
44-11	7287-7300	neighbourhood	_
44-12	7301-7313	tractography	_
44-13	7314-7315	(	_
44-14	7316-7319	PNT	_
44-15	7320-7321	)	_
44-16	7322-7323	,	_
44-17	7324-7326	as	_
44-18	7327-7338	implemented	_
44-19	7339-7341	in	_
44-20	7342-7345	the	_
44-21	7346-7353	TractoR	_
44-22	7354-7361	package	_
44-23	7362-7365	for	_
44-24	7366-7371	fibre	_
44-25	7372-7380	tracking	_
44-26	7381-7384	and	_
44-27	7385-7393	analysis	_
44-28	7394-7395	(	_
44-29	7396-7400	http	_
44-30	7401-7402	:	_
44-31	7403-7428	//www.tractor-mri.org.uk/	_
44-32	7429-7430	;	_
44-33	7431-7434	PNT	_
44-34	7435-7437	is	_
44-35	7438-7440	an	_
44-36	7441-7450	automatic	_
44-37	7451-7456	tract	_
44-38	7457-7469	segmentation	_
44-39	7470-7476	method	_
44-40	7477-7481	that	_
44-41	7482-7485	has	_
44-42	7486-7491	shown	_
44-43	7492-7496	good	_
44-44	7497-7512	reproducibility	_
44-45	7513-7514	.	_

45-1	7515-7519	This	_
45-2	7520-7529	technique	_
45-3	7530-7539	optimizes	_
45-4	7540-7543	the	_
45-5	7544-7550	choice	_
45-6	7551-7553	of	_
45-7	7554-7558	seed	_
45-8	7559-7564	point	_
45-9	7565-7574	placement	_
45-10	7575-7578	for	_
45-11	7579-7591	tractography	_
45-12	7592-7594	by	_
45-13	7595-7605	estimating	_
45-14	7606-7609	the	_
45-15	7610-7614	best	_
45-16	7615-7623	matching	_
45-17	7624-7629	tract	_
45-18	7630-7634	from	_
45-19	7635-7636	a	_
45-20	7637-7643	series	_
45-21	7644-7646	of	_
45-22	7647-7656	candidate	_
45-23	7657-7663	tracts	_
45-24	7664-7673	generated	_
45-25	7674-7678	from	_
45-26	7679-7680	a	_
45-27	7681-7694	neighbourhood	_
45-28	7695-7697	of	_
45-29	7698-7704	voxels	_
45-30	7705-7706	(	_
45-31	7707-7716	typically	_
45-32	7717-7718	7	_
45-33	7719-7720	×	_
45-34	7721-7722	7	_
45-35	7723-7724	×	_
45-36	7725-7726	7	_
45-37	7727-7728	)	_
45-38	7729-7735	placed	_
45-39	7736-7742	around	_
45-40	7743-7744	a	_
45-41	7745-7752	central	_
45-42	7753-7758	voxel	_
45-43	7759-7770	transferred	_
45-44	7771-7775	from	_
45-45	7776-7784	standard	_
45-46	7785-7787	to	_
45-47	7788-7794	native	_
45-48	7795-7800	space	_
45-49	7801-7808	against	_
45-50	7809-7810	a	_
45-51	7811-7820	reference	_
45-52	7821-7826	tract	_
45-53	7827-7831	that	_
45-54	7832-7835	was	_
45-55	7836-7843	derived	_
45-56	7844-7848	from	_
45-57	7849-7850	a	_
45-58	7851-7856	group	_
45-59	7857-7859	of	_
45-60	7860-7867	healthy	_
45-61	7868-7878	volunteers	_
45-62	7879-7883	aged	_
45-63	7884-7889	25–64	_
45-64	7890-7895	years	_
45-65	7896-7897	.	_

46-1	7898-7901	The	_
46-2	7902-7913	topological	_
46-3	7914-7919	tract	_
46-4	7920-7925	model	_
46-5	7926-7929	was	_
46-6	7930-7934	also	_
46-7	7935-7939	used	_
46-8	7940-7942	to	_
46-9	7943-7949	reject	_
46-10	7950-7953	any	_
46-11	7954-7959	false	_
46-12	7960-7968	positive	_
46-13	7969-7980	connections	_
46-14	7981-7982	,	_
46-15	7983-7990	thereby	_
46-16	7991-8004	significantly	_
46-17	8005-8014	improving	_
46-18	8015-8020	tract	_
46-19	8021-8033	segmentation	_
46-20	8034-8035	.	_

47-1	8036-8039	The	_
47-2	8040-8044	seed	_
47-3	8045-8050	point	_
47-4	8051-8055	best	_
47-5	8056-8064	matching	_
47-6	8065-8069	each	_
47-7	8070-8075	tract	_
47-8	8076-8078	to	_
47-9	8079-8082	the	_
47-10	8083-8092	reference	_
47-11	8093-8096	was	_
47-12	8097-8107	determined	_
47-13	8108-8110	in	_
47-14	8111-8115	this	_
47-15	8116-8122	manner	_
47-16	8123-8126	and	_
47-17	8127-8140	probabilistic	_
47-18	8141-8146	white	_
47-19	8147-8153	matter	_
47-20	8154-8160	tracts	_
47-21	8161-8166	masks	_
47-22	8167-8171	were	_
47-23	8172-8185	reconstructed	_
47-24	8186-8188	by	_
47-25	8189-8197	sampling	_
47-26	8198-8202	5000	_
47-27	8203-8214	streamlines	_
47-28	8215-8216	.	_

48-1	8217-8220	All	_
48-2	8221-8230	segmented	_
48-3	8231-8236	white	_
48-4	8237-8243	matter	_
48-5	8244-8250	tracts	_
48-6	8251-8255	were	_
48-7	8256-8264	visually	_
48-8	8265-8273	assessed	_
48-9	8274-8276	to	_
48-10	8277-8283	ensure	_
48-11	8284-8288	they	_
48-12	8289-8293	were	_
48-13	8294-8296	an	_
48-14	8297-8309	anatomically	_
48-15	8310-8318	accurate	_
48-16	8319-8333	representation	_
48-17	8334-8336	of	_
48-18	8337-8340	the	_
48-19	8341-8362	fasciculi-of-interest	_
48-20	8363-8364	.	_

49-1	8365-8368	The	_
49-2	8369-8378	resulting	_
49-3	8379-8391	tractography	_
49-4	8392-8397	masks	_
49-5	8398-8402	were	_
49-6	8403-8410	applied	_
49-7	8411-8413	to	_
49-8	8414-8417	the	_
49-9	8418-8423	MD/FA	_
49-10	8424-8431	volumes	_
49-11	8432-8434	of	_
49-12	8435-8439	each	_
49-13	8440-8451	participant	_
49-14	8452-8453	;	_
49-15	8454-8458	this	_
49-16	8459-8468	permitted	_
49-17	8469-8483	tract-specific	_
49-18	8484-8488	mean	_
49-19	8489-8495	values	_
49-20	8496-8498	of	_
49-21	8499-8501	FA	_
49-22	8502-8505	and	_
49-23	8506-8508	MD	_
49-24	8509-8510	,	_
49-25	8511-8519	weighted	_
49-26	8520-8522	by	_
49-27	8523-8526	the	_
49-28	8527-8537	connection	_
49-29	8538-8549	probability	_
49-30	8550-8551	,	_
49-31	8552-8554	to	_
49-32	8555-8557	be	_
49-33	8558-8566	obtained	_
49-34	8567-8570	for	_
49-35	8571-8575	each	_
49-36	8576-8581	tract	_
49-37	8582-8584	in	_
49-38	8585-8589	each	_
49-39	8590-8597	subject	_
49-40	8598-8599	.	_

50-1	8600-8603	The	_
50-2	8604-8610	twelve	_
50-3	8611-8617	tracts	_
50-4	8618-8627	segmented	_
50-5	8628-8632	were	_
50-6	8633-8636	the	_
50-7	8637-8641	genu	_
50-8	8642-8645	and	_
50-9	8646-8654	splenium	_
50-10	8655-8657	of	_
50-11	8658-8664	corpus	_
50-12	8665-8673	callosum	_
50-13	8674-8675	,	_
50-14	8676-8679	and	_
50-15	8680-8689	bilateral	_
50-16	8690-8698	cingulum	_
50-17	8699-8700	,	_
50-18	8701-8709	anterior	_
50-19	8710-8718	thalamic	_
50-20	8719-8729	radiations	_
50-21	8730-8731	(	_
50-22	8732-8735	ATR	_
50-23	8736-8737	)	_
50-24	8738-8739	,	_
50-25	8740-8747	arcuate	_
50-26	8748-8749	,	_
50-27	8750-8758	uncinate	_
50-28	8759-8762	and	_
50-29	8763-8771	inferior	_
50-30	8772-8784	longitudinal	_
50-31	8785-8794	fasciculi	_
50-32	8795-8796	.	_

51-1	8797-8807	Structural	_
51-2	8808-8818	connectome	_
51-3	8819-8824	Using	_
51-4	8825-8828	the	_
51-5	8829-8840	probability	_
51-6	8841-8848	density	_
51-7	8849-8858	functions	_
51-8	8859-8868	generated	_
51-9	8869-8873	from	_
51-10	8874-8893	BedpostX/ProbTractX	_
51-11	8894-8895	,	_
51-12	8896-8907	streamlines	_
51-13	8908-8912	were	_
51-14	8913-8917	then	_
51-15	8918-8929	constructed	_
51-16	8930-8932	by	_
51-17	8933-8941	sampling	_
51-18	8942-8946	from	_
51-19	8947-8952	these	_
51-20	8953-8966	distributions	_
51-21	8967-8973	during	_
51-22	8974-8975	a	_
51-23	8976-8984	tracking	_
51-24	8985-8992	process	_
51-25	8993-8997	that	_
51-26	8998-9006	involved	_
51-27	9007-9010	all	_
51-28	9011-9016	white	_
51-29	9017-9023	matter	_
51-30	9024-9030	voxels	_
51-31	9031-9036	using	_
51-32	9037-9040	100	_
51-33	9041-9047	Markov	_
51-34	9048-9053	Chain	_
51-35	9054-9059	Monte	_
51-36	9060-9065	Carlo	_
51-37	9066-9076	iterations	_
51-38	9077-9081	with	_
51-39	9082-9083	a	_
51-40	9084-9088	ﬁxed	_
51-41	9089-9093	step	_
51-42	9094-9098	size	_
51-43	9099-9101	of	_
51-44	9102-9105	0.5	_
51-45	9106-9108	mm	_
51-46	9109-9116	between	_
51-47	9117-9127	successive	_
51-48	9128-9134	points	_
51-49	9135-9136	.	_

52-1	9137-9145	Tracking	_
52-2	9146-9149	was	_
52-3	9150-9159	initiated	_
52-4	9160-9164	from	_
52-5	9165-9168	all	_
52-6	9169-9174	white	_
52-7	9175-9181	matter	_
52-8	9182-9188	voxels	_
52-9	9189-9191	in	_
52-10	9192-9195	two	_
52-11	9196-9205	collinear	_
52-12	9206-9216	directions	_
52-13	9217-9222	until	_
52-14	9223-9233	terminated	_
52-15	9234-9236	by	_
52-16	9237-9240	the	_
52-17	9241-9250	following	_
52-18	9251-9259	stopping	_
52-19	9260-9268	criteria	_
52-20	9269-9277	designed	_
52-21	9278-9280	to	_
52-22	9281-9289	minimize	_
52-23	9290-9293	the	_
52-24	9294-9300	amount	_
52-25	9301-9303	of	_
52-26	9304-9316	anatomically	_
52-27	9317-9328	implausible	_
52-28	9329-9340	streamlines	_
52-29	9341-9342	:	_
52-30	9343-9344	(	_
52-31	9345-9346	i	_
52-32	9347-9348	)	_
52-33	9349-9358	exceeding	_
52-34	9359-9360	a	_
52-35	9361-9370	curvature	_
52-36	9371-9380	threshold	_
52-37	9381-9383	of	_
52-38	9384-9387	70°	_
52-39	9388-9389	;	_
52-40	9390-9391	(	_
52-41	9392-9394	ii	_
52-42	9395-9396	)	_
52-43	9397-9405	entering	_
52-44	9406-9407	a	_
52-45	9408-9413	voxel	_
52-46	9414-9418	with	_
52-47	9419-9421	FA	_
52-48	9422-9427	below	_
52-49	9428-9431	0.1	_
52-50	9432-9433	;	_
52-51	9434-9435	(	_
52-52	9436-9439	iii	_
52-53	9440-9441	)	_
52-54	9442-9450	entering	_
52-55	9451-9453	an	_
52-56	9454-9468	extra-cerebral	_
52-57	9469-9474	voxel	_
52-58	9475-9476	;	_
52-59	9477-9478	(	_
52-60	9479-9481	iv	_
52-61	9482-9483	)	_
52-62	9484-9493	exceeding	_
52-63	9494-9497	200	_
52-64	9498-9500	mm	_
52-65	9501-9503	in	_
52-66	9504-9510	length	_
52-67	9511-9512	;	_
52-68	9513-9516	and	_
52-69	9517-9518	(	_
52-70	9519-9520	v	_
52-71	9521-9522	)	_
52-72	9523-9532	exceeding	_
52-73	9533-9534	a	_
52-74	9535-9543	distance	_
52-75	9544-9549	ratio	_
52-76	9550-9556	metric	_
52-77	9557-9559	of	_
52-78	9560-9562	10	_
52-79	9563-9564	.	_

53-1	9565-9568	The	_
53-2	9569-9577	distance	_
53-3	9578-9583	ratio	_
53-4	9584-9590	metric	_
53-5	9591-9592	,	_
53-6	9593-9601	excludes	_
53-7	9602-9613	implausibly	_
53-8	9614-9622	tortuous	_
53-9	9623-9634	streamlines	_
53-10	9635-9636	.	_

54-1	9637-9640	For	_
54-2	9641-9649	instance	_
54-3	9650-9651	,	_
54-4	9652-9653	a	_
54-5	9654-9664	streamline	_
54-6	9665-9669	with	_
54-7	9670-9671	a	_
54-8	9672-9677	total	_
54-9	9678-9682	path	_
54-10	9683-9689	length	_
54-11	9690-9692	10	_
54-12	9693-9698	times	_
54-13	9699-9705	longer	_
54-14	9706-9710	than	_
54-15	9711-9714	the	_
54-16	9715-9723	distance	_
54-17	9724-9731	between	_
54-18	9732-9735	end	_
54-19	9736-9742	points	_
54-20	9743-9746	was	_
54-21	9747-9757	considered	_
54-22	9758-9760	to	_
54-23	9761-9763	be	_
54-24	9764-9771	invalid	_
54-25	9772-9773	.	_

55-1	9774-9777	The	_
55-2	9778-9784	values	_
55-3	9785-9787	of	_
55-4	9788-9791	the	_
55-5	9792-9801	curvature	_
55-6	9802-9803	,	_
55-7	9804-9814	anisotropy	_
55-8	9815-9818	and	_
55-9	9819-9827	distance	_
55-10	9828-9833	ratio	_
55-11	9834-9840	metric	_
55-12	9841-9852	constraints	_
55-13	9853-9857	were	_
55-14	9858-9861	set	_
55-15	9862-9873	empirically	_
55-16	9874-9877	and	_
55-17	9878-9886	informed	_
55-18	9887-9889	by	_
55-19	9890-9896	visual	_
55-20	9897-9907	assessment	_
55-21	9908-9910	of	_
55-22	9911-9914	the	_
55-23	9915-9924	resulting	_
55-24	9925-9936	streamlines	_
55-25	9937-9938	.	_

56-1	9939-9946	Network	_
56-2	9947-9959	construction	_
56-3	9960-9971	FA-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
56-4	9972-9980	networks	_
56-5	9981-9985	were	_
56-6	9986-9997	constructed	_
56-7	9998-10000	by	_
56-8	10001-10010	recording	_
56-9	10011-10014	the	_
56-10	10015-10019	mean	_
56-11	10020-10022	FA	_
56-12	10023-10028	value	_
56-13	10029-10034	along	_
56-14	10035-10046	streamlines	_
56-15	10047-10057	connecting	_
56-16	10058-10061	all	_
56-17	10062-10064	85	_
56-18	10065-10068	ROI	_
56-19	10069-10070	(	_
56-20	10071-10078	network	_
56-21	10079-10083	node	_
56-22	10084-10085	)	_
56-23	10086-10091	pairs	_
56-24	10092-10096	from	_
56-25	10097-10100	the	_
56-26	10101-10108	default	_
56-27	10109-10119	FreeSurfer	_
56-28	10120-10128	cortical	_
56-29	10129-10132	and	_
56-30	10133-10144	subcortical	_
56-31	10145-10152	regions	_
56-32	10153-10154	.	_

57-1	10155-10158	The	_
57-2	10159-10167	endpoint	_
57-3	10168-10170	of	_
57-4	10171-10172	a	_
57-5	10173-10183	streamline	_
57-6	10184-10187	was	_
57-7	10188-10198	considered	_
57-8	10199-10201	to	_
57-9	10202-10204	be	_
57-10	10205-10208	the	_
57-11	10209-10213	ﬁrst	_
57-12	10214-10218	grey	_
57-13	10219-10225	matter	_
57-14	10226-10229	ROI	_
57-15	10230-10241	encountered	_
57-16	10242-10246	when	_
57-17	10247-10255	tracking	_
57-18	10256-10260	from	_
57-19	10261-10264	the	_
57-20	10265-10269	seed	_
57-21	10270-10278	location	_
57-22	10279-10280	.	_

58-1	10281-10284	The	_
58-2	10285-10292	average	_
58-3	10293-10298	brain	_
58-4	10299-10306	network	_
58-5	10307-10313	across	_
58-6	10314-10317	the	_
58-7	10318-10324	cohort	_
58-8	10325-10328	was	_
58-9	10329-10339	determined	_
58-10	10340-10342	by	_
58-11	10343-10352	including	_
58-12	10353-10358	those	_
58-13	10359-10370	connections	_
58-14	10371-10376	which	_
58-15	10377-10385	occurred	_
58-16	10386-10388	in	_
58-17	10389-10393	more	_
58-18	10394-10398	than	_
58-19	10399-10402	2/3	_
58-20	10403-10405	of	_
58-21	10406-10409	the	_
58-22	10410-10422	participants	_
58-23	10423-10425	at	_
58-24	10426-10434	baseline	_
58-25	10435-10436	.	_

59-1	10437-10441	This	_
59-2	10442-10450	baseline	_
59-3	10451-10458	network	_
59-4	10459-10463	mask	_
59-5	10464-10467	was	_
59-6	10468-10472	then	_
59-7	10473-10483	propagated	_
59-8	10484-10486	to	_
59-9	10487-10490	the	_
59-10	10491-10497	second	_
59-11	10498-10502	wave	_
59-12	10503-10505	of	_
59-13	10506-10518	connectivity	_
59-14	10519-10527	matrices	_
59-15	10528-10529	.	_

60-1	10530-10544	Organizational	_
60-2	10545-10555	properties	_
60-3	10556-10558	of	_
60-4	10559-10562	the	_
60-5	10563-10572	different	_
60-6	10573-10581	networks	_
60-7	10582-10586	were	_
60-8	10587-10591	then	_
60-9	10592-10600	obtained	_
60-10	10601-10606	using	_
60-11	10607-10610	the	_
60-12	10611-10616	brain	_
60-13	10617-10629	connectivity	_
60-14	10630-10637	toolbox	_
60-15	10638-10639	(	_
60-16	10640-10674	www.brain-connectivity-toolbox.net	_
60-17	10675-10676	)	_
60-18	10677-10678	.	_

61-1	10679-10682	For	_
61-2	10683-10687	each	_
61-3	10688-10699	FA-weighted	_
61-4	10700-10712	connectivity	_
61-5	10713-10719	matrix	_
61-6	10720-10723	for	_
61-7	10724-10727	the	_
61-8	10728-10735	average	_
61-9	10736-10743	network	_
61-10	10744-10745	,	_
61-11	10746-10750	five	_
61-12	10751-10757	global	_
61-13	10758-10765	network	_
61-14	10766-10774	measures	_
61-15	10775-10779	were	_
61-16	10780-10788	computed	_
61-17	10789-10790	,	_
61-18	10791-10797	namely	_
61-19	10798-10802	mean	_
61-20	10803-10807	edge	_
61-21	10808-10814	weight	_
61-22	10815-10816	(	_
61-23	10817-10821	mean	_
61-24	10822-10827	value	_
61-25	10828-10830	of	_
61-26	10831-10833	FA	_
61-27	10834-10840	across	_
61-28	10841-10844	the	_
61-29	10845-10852	network	_
61-30	10853-10854	)	_
61-31	10855-10856	,	_
61-32	10857-10864	density	_
61-33	10865-10866	(	_
61-34	10867-10870	the	_
61-35	10871-10879	fraction	_
61-36	10880-10882	of	_
61-37	10883-10890	present	_
61-38	10891-10902	connections	_
61-39	10903-10905	to	_
61-40	10906-10914	possible	_
61-41	10915-10926	connections	_
61-42	10927-10928	)	_
61-43	10929-10930	,	_
61-44	10931-10939	strength	_
61-45	10940-10941	(	_
61-46	10942-10945	the	_
61-47	10946-10953	average	_
61-48	10954-10957	sum	_
61-49	10958-10960	of	_
61-50	10961-10968	weights	_
61-51	10969-10972	per	_
61-52	10973-10977	node	_
61-53	10978-10979	)	_
61-54	10980-10981	,	_
61-55	10982-10992	clustering	_
61-56	10993-11003	coefﬁcient	_
61-57	11004-11005	(	_
61-58	11006-11014	fraction	_
61-59	11015-11017	of	_
61-60	11018-11027	triangles	_
61-61	11028-11034	around	_
61-62	11035-11036	a	_
61-63	11037-11041	node	_
61-64	11042-11043	)	_
61-65	11044-11047	and	_
61-66	11048-11054	global	_
61-67	11055-11064	efﬁciency	_
61-68	11065-11066	(	_
61-69	11067-11070	the	_
61-70	11071-11078	average	_
61-71	11079-11081	of	_
61-72	11082-11085	the	_
61-73	11086-11093	inverse	_
61-74	11094-11102	shortest	_
61-75	11103-11107	path	_
61-76	11108-11114	length	_
61-77	11115-11116	)	_
61-78	11117-11118	.	_

62-1	11119-11128	Polygenic	_
62-2	11129-11133	risk	_
62-3	11134-11139	score	_
62-4	11140-11151	calculation	_
62-5	11152-11155	The	_
62-6	11156-11164	majority	_
62-7	11165-11167	of	_
62-8	11168-11180	participants	_
62-9	11181-11189	provided	_
62-10	11190-11195	blood	_
62-11	11196-11203	samples	_
62-12	11204-11206	at	_
62-13	11207-11210	the	_
62-14	11211-11216	first	_
62-15	11217-11224	testing	_
62-16	11225-11229	wave	_
62-17	11230-11231	(	_
62-18	11232-11235	age	_
62-19	11236-11238	70	_
62-20	11239-11244	years	_
62-21	11245-11246	)	_
62-22	11247-11251	that	_
62-23	11252-11256	were	_
62-24	11257-11261	used	_
62-25	11262-11264	to	_
62-26	11265-11272	extract	_
62-27	11273-11276	DNA	_
62-28	11277-11280	for	_
62-29	11281-11284	the	_
62-30	11285-11292	genetic	_
62-31	11293-11301	analyses	_
62-32	11302-11303	.	_

63-1	11304-11306	To	_
63-2	11307-11314	measure	_
63-3	11315-11332	single-nucleotide	_
63-4	11333-11346	polymorphisms	_
63-5	11347-11348	(	_
63-6	11349-11353	SNPs	_
63-7	11354-11355	)	_
63-8	11356-11358	we	_
63-9	11359-11363	used	_
63-10	11364-11367	the	_
63-11	11368-11376	Illumina	_
63-12	11377-11387	610-Quadv1	_
63-13	11388-11400	whole-genome	_
63-14	11401-11404	SNP	_
63-15	11405-11410	array	_
63-16	11411-11412	;	_
63-17	11413-11425	measurements	_
63-18	11426-11430	were	_
63-19	11431-11440	completed	_
63-20	11441-11443	at	_
63-21	11444-11447	the	_
63-22	11448-11456	Wellcome	_
63-23	11457-11462	Trust	_
63-24	11463-11471	Clinical	_
63-25	11472-11480	Research	_
63-26	11481-11489	Facility	_
63-27	11490-11498	Genetics	_
63-28	11499-11503	Core	_
63-29	11504-11505	,	_
63-30	11506-11513	Western	_
63-31	11514-11521	General	_
63-32	11522-11530	Hospital	_
63-33	11531-11532	,	_
63-34	11533-11542	Edinburgh	_
63-35	11543-11544	(	_
63-36	11545-11550	https	_
63-37	11551-11552	:	_
63-38	11553-11573	//www.wtcrf.ed.ac.uk	_
63-39	11574-11575	)	_
63-40	11576-11577	.	_

64-1	11578-11587	Stringent	_
64-2	11588-11595	quality	_
64-3	11596-11603	control	_
64-4	11604-11612	analyses	_
64-5	11613-11617	were	_
64-6	11618-11625	applied	_
64-7	11626-11628	to	_
64-8	11629-11632	the	_
64-9	11633-11641	genotype	_
64-10	11642-11646	data	_
64-11	11647-11652	which	_
64-12	11653-11661	resulted	_
64-13	11662-11664	in	_
64-14	11665-11671	549692	_
64-15	11672-11674	of	_
64-16	11675-11678	the	_
64-17	11679-11685	599011	_
64-18	11686-11690	SNPs	_
64-19	11691-11693	on	_
64-20	11694-11697	the	_
64-21	11698-11706	Illumina	_
64-22	11707-11710	610	_
64-23	11711-11715	chip	_
64-24	11716-11721	being	_
64-25	11722-11730	retained	_
64-26	11731-11733	in	_
64-27	11734-11738	3511	_
64-28	11739-11750	individuals	_
64-29	11751-11752	(	_
64-30	11753-11757	2115	_
64-31	11758-11765	females	_
64-32	11766-11767	)	_
64-33	11768-11769	.	_

65-1	11770-11773	The	_
65-2	11774-11780	sample	_
65-3	11781-11791	collection	_
65-4	11792-11793	,	_
65-5	11794-11801	quality	_
65-6	11802-11809	control	_
65-7	11810-11813	and	_
65-8	11814-11824	genotyping	_
65-9	11825-11832	process	_
65-10	11833-11835	is	_
65-11	11836-11845	described	_
65-12	11846-11848	in	_
65-13	11849-11856	greater	_
65-14	11857-11863	detail	_
65-15	11864-11873	elsewhere	_
65-16	11874-11877	and	_
65-17	11878-11890	non-European	_
65-18	11891-11902	individuals	_
65-19	11903-11907	were	_
65-20	11908-11917	carefully	_
65-21	11918-11926	excluded	_
65-22	11927-11931	from	_
65-23	11932-11935	the	_
65-24	11936-11943	current	_
65-25	11944-11952	analysis	_
65-26	11953-11954	.	_

66-1	11955-11959	PGRS	_
66-2	11960-11969	summarise	_
66-3	11970-11973	the	_
66-4	11974-11979	small	_
66-5	11980-11987	effects	_
66-6	11988-11994	across	_
66-7	11995-11998	all	_
66-8	11999-12003	SNPs	_
66-9	12004-12008	that	_
66-10	12009-12019	contribute	_
66-11	12020-12022	to	_
66-12	12023-12026	the	_
66-13	12027-12034	genetic	_
66-14	12035-12044	liability	_
66-15	12045-12047	of	_
66-16	12048-12049	a	_
66-17	12050-12059	phenotype	_
66-18	12060-12061	(	_
66-19	12062-12064	in	_
66-20	12065-12069	this	_
66-21	12070-12074	case	_
66-22	12075-12076	,	_
66-23	12077-12090	schizophrenia	_
66-24	12091-12092	)	_
66-25	12093-12094	.	_

67-1	12095-12098	The	_
67-2	12099-12112	out-of-sample	_
67-3	12113-12123	validation	_
67-4	12124-12126	of	_
67-5	12127-12130	the	_
67-6	12131-12139	capacity	_
67-7	12140-12142	of	_
67-8	12143-12149	szPGRS	_
67-9	12150-12152	to	_
67-10	12153-12160	predict	_
67-11	12161-12166	onset	_
67-12	12167-12169	of	_
67-13	12170-12183	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
67-14	12184-12187	has	_
67-15	12188-12192	been	_
67-16	12193-12201	reported	_
67-17	12202-12204	to	_
67-18	12205-12212	explain	_
67-19	12213-12218	24.43	_
67-20	12219-12220	%	_
67-21	12221-12222	(	_
67-22	12223-12226	the	_
67-23	12227-12235	estimate	_
67-24	12236-12243	assumes	_
67-25	12244-12245	a	_
67-26	12246-12256	population	_
67-27	12257-12261	risk	_
67-28	12262-12264	of	_
67-29	12265-12266	1	_
67-30	12267-12268	%	_
67-31	12269-12270	)	_
67-32	12271-12273	of	_
67-33	12274-12277	the	_
67-34	12278-12286	variance	_
67-35	12287-12289	in	_
67-36	12290-12299	liability	_
67-37	12300-12301	.	_

68-1	12302-12308	szPGRS	_
68-2	12309-12313	were	_
68-3	12314-12321	created	_
68-4	12322-12325	for	_
68-5	12326-12329	all	_
68-6	12330-12341	individuals	_
68-7	12342-12346	with	_
68-8	12347-12355	suitable	_
68-9	12356-12364	genotype	_
68-10	12365-12369	data	_
68-11	12370-12371	;	_
68-12	12372-12376	only	_
68-13	12377-12386	genotypes	_
68-14	12387-12394	passing	_
68-15	12395-12404	stringent	_
68-16	12405-12412	quality	_
68-17	12413-12420	control	_
68-18	12421-12425	were	_
68-19	12426-12430	used	_
68-20	12431-12433	in	_
68-21	12434-12442	analyses	_
68-22	12443-12444	.	_

69-1	12445-12451	szPGRS	_
69-2	12452-12456	were	_
69-3	12457-12466	estimated	_
69-4	12467-12472	using	_
69-5	12473-12476	the	_
69-6	12477-12483	recent	_
69-7	12484-12491	summary	_
69-8	12492-12496	data	_
69-9	12497-12501	from	_
69-10	12502-12503	a	_
69-11	12504-12508	GWAS	_
69-12	12509-12511	of	_
69-13	12512-12525	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
69-14	12526-12536	comprising	_
69-15	12537-12538	a	_
69-16	12539-12552	meta-analysis	_
69-17	12553-12555	of	_
69-18	12556-12559	two	_
69-19	12560-12567	studies	_
69-20	12568-12569	,	_
69-21	12570-12575	which	_
69-22	12576-12584	included	_
69-23	12585-12590	40675	_
69-24	12591-12596	cases	_
69-25	12597-12600	and	_
69-26	12601-12606	64643	_
69-27	12607-12615	controls	_
69-28	12616-12617	.	_

70-1	12618-12624	szPGRS	_
70-2	12625-12629	were	_
70-3	12630-12639	estimated	_
70-4	12640-12645	using	_
70-5	12646-12649	the	_
70-6	12650-12656	PRSice	_
70-7	12657-12665	software	_
70-8	12666-12673	package	_
70-9	12674-12683	according	_
70-10	12684-12686	to	_
70-11	12687-12697	previously	_
70-12	12698-12707	described	_
70-13	12708-12717	protocols	_
70-14	12718-12719	,	_
70-15	12720-12724	with	_
70-16	12725-12732	linkage	_
70-17	12733-12747	disequilibrium	_
70-18	12748-12751	and	_
70-19	12752-12760	distance	_
70-20	12761-12771	thresholds	_
70-21	12772-12775	for	_
70-22	12776-12784	clumping	_
70-23	12785-12787	of	_
70-24	12788-12790	r2	_
70-25	12791-12792	=	_
70-26	12793-12796	0.2	_
70-27	12797-12800	and	_
70-28	12801-12807	within	_
70-29	12808-12809	a	_
70-30	12810-12813	250	_
70-31	12814-12816	kb	_
70-32	12817-12823	window	_
70-33	12824-12825	.	_

71-1	12826-12830	Five	_
71-2	12831-12837	scores	_
71-3	12838-12842	were	_
71-4	12843-12850	created	_
71-5	12851-12854	for	_
71-6	12855-12859	each	_
71-7	12860-12870	individual	_
71-8	12871-12876	using	_
71-9	12877-12881	SNPs	_
71-10	12882-12890	selected	_
71-11	12891-12900	according	_
71-12	12901-12903	to	_
71-13	12904-12907	the	_
71-14	12908-12920	significance	_
71-15	12921-12923	of	_
71-16	12924-12929	their	_
71-17	12930-12941	association	_
71-18	12942-12946	with	_
71-19	12947-12950	the	_
71-20	12951-12960	phenotype	_
71-21	12961-12963	at	_
71-22	12964-12971	nominal	_
71-23	12972-12979	p-value	_
71-24	12980-12990	thresholds	_
71-25	12991-12993	of	_
71-26	12994-12998	0.01	_
71-27	12999-13000	,	_
71-28	13001-13005	0.05	_
71-29	13006-13007	,	_
71-30	13008-13011	0.1	_
71-31	13012-13013	,	_
71-32	13014-13017	0.5	_
71-33	13018-13021	and	_
71-34	13022-13025	1.0	_
71-35	13026-13027	(	_
71-36	13028-13031	all	_
71-37	13032-13036	SNPs	_
71-38	13037-13038	)	_
71-39	13039-13040	.	_

72-1	13041-13044	Our	_
72-2	13045-13052	primary	_
72-3	13053-13061	analyses	_
72-4	13062-13066	used	_
72-5	13067-13073	scores	_
72-6	13074-13083	generated	_
72-7	13084-13088	from	_
72-8	13089-13090	a	_
72-9	13091-13095	list	_
72-10	13096-13098	of	_
72-11	13099-13103	SNPs	_
72-12	13104-13108	with	_
72-13	13109-13110	a	_
72-14	13111-13115	GWAS	_
72-15	13116-13124	training	_
72-16	13125-13128	set	_
72-17	13129-13131	of	_
72-18	13132-13133	p	_
72-19	13134-13135	≤	_
72-20	13136-13139	1.0	_
72-21	13140-13149	threshold	_
72-22	13150-13152	as	_
72-23	13153-13164	recommended	_
72-24	13165-13175	previously	_
72-25	13176-13178	in	_
72-26	13179-13184	order	_
72-27	13185-13187	to	_
72-28	13188-13193	allow	_
72-29	13194-13205	replication	_
72-30	13206-13208	by	_
72-31	13209-13214	other	_
72-32	13215-13222	studies	_
72-33	13223-13226	and	_
72-34	13227-13229	to	_
72-35	13230-13238	maximise	_
72-36	13239-13242	the	_
72-37	13243-13252	potential	_
72-38	13253-13263	predictive	_
72-39	13264-13272	capacity	_
72-40	13273-13274	.	_

73-1	13275-13282	However	_
73-2	13283-13284	,	_
73-3	13285-13292	results	_
73-4	13293-13295	at	_
73-5	13296-13297	p	_
73-6	13298-13299	≤	_
73-7	13300-13303	0.1	_
73-8	13304-13307	and	_
73-9	13308-13309	p	_
73-10	13310-13311	≤	_
73-11	13312-13315	0.5	_
73-12	13316-13326	thresholds	_
73-13	13327-13330	are	_
73-14	13331-13340	presented	_
73-15	13341-13343	in	_
73-16	13344-13357	Supplementary	_
73-17	13358-13366	Material	_
73-18	13367-13373	Tables	_
73-19	13374-13375	3	_
73-20	13376-13379	and	_
73-21	13380-13381	4	_
73-22	13382-13386	Four	_
73-23	13387-13403	multidimensional	_
73-24	13404-13411	scaling	_
73-25	13412-13419	factors	_
73-26	13420-13421	(	_
73-27	13422-13431	estimated	_
73-28	13432-13436	from	_
73-29	13437-13440	SNP	_
73-30	13441-13445	data	_
73-31	13446-13447	)	_
73-32	13448-13452	were	_
73-33	13453-13460	entered	_
73-34	13461-13465	into	_
73-35	13466-13469	the	_
73-36	13470-13476	models	_
73-37	13477-13479	as	_
73-38	13480-13490	additional	_
73-39	13491-13492	‘	_
73-40	13493-13501	nuisance	_
73-41	13502-13503	’	_
73-42	13504-13514	covariates	_
73-43	13515-13517	to	_
73-44	13518-13525	control	_
73-45	13526-13529	for	_
73-46	13530-13540	population	_
73-47	13541-13555	stratification	_
73-48	13556-13557	,	_
73-49	13558-13563	along	_
73-50	13564-13568	with	_
73-51	13569-13572	age	_
73-52	13573-13574	.	_

74-1	13575-13580	These	_
74-2	13581-13597	multidimensional	_
74-3	13598-13605	scaling	_
74-4	13606-13613	factors	_
74-5	13614-13618	have	_
74-6	13619-13623	been	_
74-7	13624-13634	previously	_
74-8	13635-13645	identified	_
74-9	13646-13648	to	_
74-10	13649-13651	be	_
74-11	13652-13660	adequate	_
74-12	13661-13664	for	_
74-13	13665-13675	accounting	_
74-14	13676-13679	for	_
74-15	13680-13690	population	_
74-16	13691-13700	structure	_
74-17	13701-13703	in	_
74-18	13704-13708	this	_
74-19	13709-13715	sample	_
74-20	13716-13717	.	_

75-1	13718-13729	Statistical	_
75-2	13730-13738	analyses	_
75-3	13739-13744	First	_
75-4	13745-13746	,	_
75-5	13747-13758	age-related	_
75-6	13759-13766	changes	_
75-7	13767-13770	for	_
75-8	13771-13776	white	_
75-9	13777-13783	matter	_
75-10	13784-13789	tract	_
75-11	13790-13795	MD/FA	_
75-12	13796-13802	values	_
75-13	13803-13806	and	_
75-14	13807-13813	global	_
75-15	13814-13819	graph	_
75-16	13820-13826	theory	_
75-17	13827-13835	measures	_
75-18	13836-13840	were	_
75-19	13841-13851	calculated	_
75-20	13852-13857	using	_
75-21	13858-13864	linear	_
75-22	13865-13870	mixed	_
75-23	13871-13877	models	_
75-24	13878-13881	for	_
75-25	13882-13887	those	_
75-26	13888-13900	participants	_
75-27	13901-13904	who	_
75-28	13905-13914	completed	_
75-29	13915-13919	both	_
75-30	13920-13931	assessments	_
75-31	13932-13933	.	_

76-1	13934-13937	The	_
76-2	13938-13945	package	_
76-3	13946-13950	used	_
76-4	13951-13954	for	_
76-5	13955-13958	the	_
76-6	13959-13965	linear	_
76-7	13966-13971	mixed	_
76-8	13972-13978	models	_
76-9	13979-13982	was	_
76-10	13983-13988	'nlme	_
76-11	13989-13990	'	_
76-12	13991-13993	in	_
76-13	13994-13995	R	_
76-14	13996-13999	and	_
76-15	14000-14012	standardised	_
76-16	14013-14018	betas	_
76-17	14019-14023	were	_
76-18	14024-14032	reported	_
76-19	14033-14034	.	_

77-1	14035-14038	Age	_
77-2	14039-14041	in	_
77-3	14042-14046	days	_
77-4	14047-14049	at	_
77-5	14050-14053	the	_
77-6	14054-14058	time	_
77-7	14059-14061	of	_
77-8	14062-14065	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
77-9	14066-14077	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
77-10	14078-14081	and	_
77-11	14082-14085	sex	_
77-12	14086-14090	were	_
77-13	14091-14098	entered	_
77-14	14099-14101	as	_
77-15	14102-14107	fixed	_
77-16	14108-14115	effects	_
77-17	14116-14119	and	_
77-18	14120-14131	participant	_
77-19	14132-14134	as	_
77-20	14135-14136	a	_
77-21	14137-14143	random	_
77-22	14144-14150	effect	_
77-23	14151-14152	.	_

78-1	14153-14161	Moreover	_
78-2	14162-14163	,	_
78-3	14164-14167	for	_
78-4	14168-14172	each	_
78-5	14173-14185	connectivity	_
78-6	14186-14192	metric	_
78-7	14193-14194	,	_
78-8	14195-14204	residuals	_
78-9	14205-14209	were	_
78-10	14210-14220	calculated	_
78-11	14221-14225	from	_
78-12	14226-14227	a	_
78-13	14228-14234	linear	_
78-14	14235-14245	regression	_
78-15	14246-14256	predicting	_
78-16	14257-14261	each	_
78-17	14262-14268	metric	_
78-18	14269-14273	from	_
78-19	14274-14281	density	_
78-20	14282-14283	(	_
78-21	14284-14292	fraction	_
78-22	14293-14295	of	_
78-23	14296-14303	present	_
78-24	14304-14315	connections	_
78-25	14316-14318	to	_
78-26	14319-14327	possible	_
78-27	14328-14339	connections	_
78-28	14340-14341	)	_
78-29	14342-14343	,	_
78-30	14344-14347	and	_
78-31	14348-14353	these	_
78-32	14354-14358	were	_
78-33	14359-14363	used	_
78-34	14364-14366	in	_
78-35	14367-14370	all	_
78-36	14371-14379	analyses	_
78-37	14380-14381	.	_

79-1	14382-14386	This	_
79-2	14387-14389	is	_
79-3	14390-14397	because	_
79-4	14398-14405	several	_
79-5	14406-14412	global	_
79-6	14413-14418	graph	_
79-7	14419-14425	theory	_
79-8	14426-14433	metrics	_
79-9	14434-14440	depend	_
79-10	14441-14443	on	_
79-11	14444-14451	density	_
79-12	14452-14455	and	_
79-13	14456-14467	comparisons	_
79-14	14468-14470	at	_
79-15	14471-14479	constant	_
79-16	14480-14487	density	_
79-17	14488-14493	allow	_
79-18	14494-14505	differences	_
79-19	14506-14513	related	_
79-20	14514-14516	to	_
79-21	14517-14520	the	_
79-22	14521-14532	topological	_
79-23	14533-14547	reorganization	_
79-24	14548-14550	of	_
79-25	14551-14556	links	_
79-26	14557-14559	to	_
79-27	14560-14562	be	_
79-28	14563-14571	assessed	_
79-29	14572-14586	longitudinally	_
79-30	14587-14588	.	_

80-1	14589-14592	The	_
80-2	14593-14596	use	_
80-3	14597-14599	of	_
80-4	14600-14605	graph	_
80-5	14606-14612	theory	_
80-6	14613-14615	to	_
80-7	14616-14621	study	_
80-8	14622-14629	network	_
80-9	14630-14638	topology	_
80-10	14639-14641	is	_
80-11	14642-14643	a	_
80-12	14644-14652	valuable	_
80-13	14653-14662	framework	_
80-14	14663-14668	while	_
80-15	14669-14673	also	_
80-16	14674-14679	being	_
80-17	14680-14681	a	_
80-18	14682-14693	challenging	_
80-19	14694-14698	task	_
80-20	14699-14700	.	_

81-1	14701-14704	For	_
81-2	14705-14713	instance	_
81-3	14714-14715	,	_
81-4	14716-14719	the	_
81-5	14720-14726	number	_
81-6	14727-14729	of	_
81-7	14730-14735	nodes	_
81-8	14736-14737	(	_
81-9	14738-14739	N	_
81-10	14740-14741	)	_
81-11	14742-14744	or	_
81-12	14745-14752	network	_
81-13	14753-14755	's	_
81-14	14756-14762	degree	_
81-15	14763-14764	(	_
81-16	14765-14766	k	_
81-17	14767-14768	)	_
81-18	14769-14773	will	_
81-19	14774-14783	influence	_
81-20	14784-14787	the	_
81-21	14788-14799	computation	_
81-22	14800-14802	of	_
81-23	14803-14809	global	_
81-24	14810-14816	theory	_
81-25	14817-14824	metrics	_
81-26	14825-14826	(	_
81-27	14827-14830	see	_
81-28	14831-14836	Brain	_
81-29	14837-14849	Connectivity	_
81-30	14850-14857	Toolbox	_
81-31	14858-14861	for	_
81-32	14862-14863	a	_
81-33	14864-14872	detailed	_
81-34	14873-14884	description	_
81-35	14885-14887	of	_
81-36	14888-14895	metrics	_
81-37	14896-14897	:	_
81-38	14898-14903	https	_
81-39	14904-14905	:	_
81-40	14906-14936	//sites.google.com/site/bctnet	_
81-41	14937-14938	)	_
81-42	14939-14940	.	_

82-1	14941-14950	Therefore	_
82-2	14951-14952	,	_
82-3	14953-14962	comparing	_
82-4	14963-14971	networks	_
82-5	14972-14976	with	_
82-6	14977-14986	different	_
82-7	14987-14988	N	_
82-8	14989-14991	or	_
82-9	14992-14993	k	_
82-10	14994-14997	can	_
82-11	14998-15003	yield	_
82-12	15004-15012	spurious	_
82-13	15013-15020	results	_
82-14	15021-15022	.	_

83-1	15023-15030	Instead	_
83-2	15031-15033	of	_
83-3	15034-15045	restraining	_
83-4	15046-15049	all	_
83-5	15050-15058	networks	_
83-6	15059-15061	to	_
83-7	15062-15063	a	_
83-8	15064-15069	fixed	_
83-9	15070-15071	k	_
83-10	15072-15081	parameter	_
83-11	15082-15083	,	_
83-12	15084-15086	we	_
83-13	15087-15092	chose	_
83-14	15093-15095	to	_
83-15	15096-15103	control	_
83-16	15104-15108	each	_
83-17	15109-15116	subject	_
83-18	15117-15119	's	_
83-19	15120-15125	graph	_
83-20	15126-15132	theory	_
83-21	15133-15140	measure	_
83-22	15141-15144	for	_
83-23	15145-15149	edge	_
83-24	15150-15157	density	_
83-25	15158-15159	.	_

84-1	15160-15169	Therefore	_
84-2	15170-15171	,	_
84-3	15172-15178	models	_
84-4	15179-15188	presented	_
84-5	15189-15194	below	_
84-6	15195-15202	compute	_
84-7	15203-15210	density	_
84-8	15211-15213	as	_
84-9	15214-15215	a	_
84-10	15216-15221	fixed	_
84-11	15222-15228	effect	_
84-12	15229-15232	for	_
84-13	15233-15237	each	_
84-14	15238-15243	graph	_
84-15	15244-15250	metric	_
84-16	15251-15252	.	_

85-1	15253-15257	This	_
85-2	15258-15265	allowed	_
85-3	15266-15268	us	_
85-4	15269-15271	to	_
85-5	15272-15279	compare	_
85-6	15280-15287	metrics	_
85-7	15288-15302	longitudinally	_
85-8	15303-15316	independently	_
85-9	15317-15319	of	_
85-10	15320-15325	their	_
85-11	15326-15337	differences	_
85-12	15338-15340	in	_
85-13	15341-15348	density	_
85-14	15349-15350	.	_

86-1	15351-15353	We	_
86-2	15354-15358	then	_
86-3	15359-15368	estimated	_
86-4	15369-15370	a	_
86-5	15371-15381	structural	_
86-6	15382-15390	equation	_
86-7	15391-15396	model	_
86-8	15397-15398	(	_
86-9	15399-15402	SEM	_
86-10	15403-15404	)	_
86-11	15405-15408	for	_
86-12	15409-15413	each	_
86-13	15414-15419	white	_
86-14	15420-15426	matter	_
86-15	15427-15432	tract	_
86-16	15433-15438	MD/FA	_
86-17	15439-15445	values	_
86-18	15446-15449	and	_
86-19	15450-15456	global	_
86-20	15457-15462	graph	_
86-21	15463-15469	theory	_
86-22	15470-15478	measures	_
86-23	15479-15480	.	_

87-1	15481-15483	We	_
87-2	15484-15493	estimated	_
87-3	15494-15495	a	_
87-4	15496-15504	separate	_
87-5	15505-15510	model	_
87-6	15511-15514	for	_
87-7	15515-15519	each	_
87-8	15520-15523	MRI	_
87-9	15524-15530	metric	_
87-10	15531-15532	(	_
87-11	15533-15550	density-corrected	_
87-12	15551-15558	network	_
87-13	15559-15565	metric	_
87-14	15566-15568	or	_
87-15	15569-15574	white	_
87-16	15575-15581	matter	_
87-17	15582-15587	tract	_
87-18	15588-15593	MD/FA	_
87-19	15594-15599	value	_
87-20	15600-15601	)	_
87-21	15602-15603	,	_
87-22	15604-15609	which	_
87-23	15610-15614	were	_
87-24	15615-15618	set	_
87-25	15619-15621	as	_
87-26	15622-15625	the	_
87-27	15626-15635	dependent	_
87-28	15636-15644	variable	_
87-29	15645-15647	in	_
87-30	15648-15652	each	_
87-31	15653-15658	model	_
87-32	15659-15660	.	_

88-1	15661-15667	Latent	_
88-2	15668-15674	change	_
88-3	15675-15680	score	_
88-4	15681-15687	models	_
88-5	15688-15692	were	_
88-6	15693-15697	used	_
88-7	15698-15700	to	_
88-8	15701-15707	assess	_
88-9	15708-15720	associations	_
88-10	15721-15723	of	_
88-11	15724-15730	szPGRS	_
88-12	15731-15735	with	_
88-13	15736-15739	the	_
88-14	15740-15755	cross-sectional	_
88-15	15756-15757	(	_
88-16	15758-15766	baseline	_
88-17	15767-15772	level	_
88-18	15773-15774	,	_
88-19	15775-15778	age	_
88-20	15779-15782	∼73	_
88-21	15783-15788	years	_
88-22	15789-15790	)	_
88-23	15791-15794	and	_
88-24	15795-15807	longitudinal	_
88-25	15808-15814	change	_
88-26	15815-15816	(	_
88-27	15817-15822	73–76	_
88-28	15823-15828	years	_
88-29	15829-15830	)	_
88-30	15831-15833	in	_
88-31	15834-15843	diffusion	_
88-32	15844-15847	MRI	_
88-33	15848-15858	parameters	_
88-34	15859-15860	.	_

89-1	15861-15867	Latent	_
89-2	15868-15874	scores	_
89-3	15875-15879	were	_
89-4	15880-15887	derived	_
89-5	15888-15892	from	_
89-6	15893-15902	bilateral	_
89-7	15903-15908	white	_
89-8	15909-15915	matter	_
89-9	15916-15922	tracts	_
89-10	15923-15924	.	_

90-1	15925-15927	We	_
90-2	15928-15939	constrained	_
90-3	15940-15943	the	_
90-4	15944-15952	loadings	_
90-5	15953-15956	for	_
90-6	15957-15961	left	_
90-7	15962-15965	and	_
90-8	15966-15971	right	_
90-9	15972-15978	tracts	_
90-10	15979-15985	across	_
90-11	15986-15991	waves	_
90-12	15992-15994	to	_
90-13	15995-15997	be	_
90-14	15998-16003	equal	_
90-15	16004-16005	(	_
90-16	16006-16009	i.e	_
90-17	16010-16011	.	_

91-1	16012-16015	the	_
91-2	16016-16020	left	_
91-3	16021-16029	loadings	_
91-4	16030-16034	were	_
91-5	16035-16040	equal	_
91-6	16041-16047	across	_
91-7	16048-16053	waves	_
91-8	16054-16057	and	_
91-9	16058-16069	independent	_
91-10	16070-16072	of	_
91-11	16073-16078	right	_
91-12	16079-16087	loadings	_
91-13	16088-16089	)	_
91-14	16090-16091	.	_

92-1	16092-16095	For	_
92-2	16096-16112	interhemispheric	_
92-3	16113-16118	white	_
92-4	16119-16125	matter	_
92-5	16126-16132	tracts	_
92-6	16133-16134	(	_
92-7	16135-16139	genu	_
92-8	16140-16143	and	_
92-9	16144-16152	splenium	_
92-10	16153-16154	)	_
92-11	16155-16158	and	_
92-12	16159-16164	graph	_
92-13	16165-16171	theory	_
92-14	16172-16179	metrics	_
92-15	16180-16181	,	_
92-16	16182-16184	we	_
92-17	16185-16189	used	_
92-18	16190-16191	a	_
92-19	16192-16198	single	_
92-20	16199-16208	indicator	_
92-21	16209-16214	model	_
92-22	16215-16216	.	_

93-1	16217-16220	Fig	_
93-2	16221-16222	.	_

94-1	16223-16224	1	_
94-2	16225-16230	shows	_
94-3	16231-16232	a	_
94-4	16233-16243	simplified	_
94-5	16244-16251	diagram	_
94-6	16252-16254	of	_
94-7	16255-16258	the	_
94-8	16259-16262	SEM	_
94-9	16263-16272	framework	_
94-10	16273-16274	.	_

95-1	16275-16281	Within	_
95-2	16282-16285	the	_
95-3	16286-16291	model	_
95-4	16292-16293	,	_
95-5	16294-16298	each	_
95-6	16299-16304	brain	_
95-7	16305-16312	imaging	_
95-8	16313-16320	measure	_
95-9	16321-16324	was	_
95-10	16325-16333	adjusted	_
95-11	16334-16337	for	_
95-12	16338-16341	its	_
95-13	16342-16352	respective	_
95-14	16353-16356	age	_
95-15	16357-16359	in	_
95-16	16360-16364	days	_
95-17	16365-16367	at	_
95-18	16368-16371	the	_
95-19	16372-16376	time	_
95-20	16377-16379	of	_
95-21	16380-16388	scanning	_
95-22	16389-16392	and	_
95-23	16393-16396	sex	_
95-24	16397-16399	at	_
95-25	16400-16403	the	_
95-26	16404-16412	manifest	_
95-27	16413-16418	level	_
95-28	16419-16420	,	_
95-29	16421-16426	while	_
95-30	16427-16433	szPGRS	_
95-31	16434-16437	was	_
95-32	16438-16446	adjusted	_
95-33	16447-16450	for	_
95-34	16451-16454	sex	_
95-35	16455-16458	and	_
95-36	16459-16469	population	_
95-37	16470-16484	stratification	_
95-38	16485-16495	components	_
95-39	16496-16497	.	_

96-1	16498-16501	Due	_
96-2	16502-16504	to	_
96-3	16505-16508	the	_
96-4	16509-16517	apparent	_
96-5	16518-16529	association	_
96-6	16530-16537	between	_
96-7	16538-16551	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
96-8	16552-16555	and	_
96-9	16556-16570	cardiovascular	_
96-10	16571-16578	disease	_
96-11	16579-16580	,	_
96-12	16581-16583	we	_
96-13	16584-16592	adjusted	_
96-14	16593-16596	the	_
96-15	16597-16603	linear	_
96-16	16604-16609	mixed	_
96-17	16610-16616	models	_
96-18	16617-16620	and	_
96-19	16621-16627	latent	_
96-20	16628-16634	change	_
96-21	16635-16640	score	_
96-22	16641-16647	models	_
96-23	16648-16651	for	_
96-24	16652-16656	high	_
96-25	16657-16662	blood	_
96-26	16663-16671	pressure	_
96-27	16672-16674	at	_
96-28	16675-16679	each	_
96-29	16680-16684	time	_
96-30	16685-16690	point	_
96-31	16691-16693	in	_
96-32	16694-16699	order	_
96-33	16700-16702	to	_
96-34	16703-16709	reject	_
96-35	16710-16713	the	_
96-36	16714-16724	hypothesis	_
96-37	16725-16729	that	_
96-38	16730-16736	higher	_
96-39	16737-16751	cardiovascular	_
96-40	16752-16756	risk	_
96-41	16757-16760	may	_
96-42	16761-16771	contribute	_
96-43	16772-16774	to	_
96-44	16775-16776	a	_
96-45	16777-16784	steeper	_
96-46	16785-16792	decline	_
96-47	16793-16795	in	_
96-48	16796-16805	diffusion	_
96-49	16806-16809	MRI	_
96-50	16810-16820	parameters	_
96-51	16821-16825	over	_
96-52	16826-16830	time	_
96-53	16831-16832	.	_

97-1	16833-16836	For	_
97-2	16837-16841	each	_
97-3	16842-16847	model	_
97-4	16848-16849	,	_
97-5	16850-16852	we	_
97-6	16853-16859	tested	_
97-7	16860-16863	the	_
97-8	16864-16875	association	_
97-9	16876-16878	at	_
97-10	16879-16882	the	_
97-11	16883-16888	brain	_
97-12	16889-16897	baseline	_
97-13	16898-16903	level	_
97-14	16904-16907	and	_
97-15	16908-16914	change	_
97-16	16915-16919	with	_
97-17	16920-16926	szPGRS	_
97-18	16927-16928	.	_

98-1	16929-16932	SEM	_
98-2	16933-16936	was	_
98-3	16937-16946	performed	_
98-4	16947-16952	using	_
98-5	16953-16956	the	_
98-6	16957-16964	package	_
98-7	16965-16972	'lavaan	_
98-8	16973-16974	'	_
98-9	16975-16977	in	_
98-10	16978-16979	R	_
98-11	16980-16984	with	_
98-12	16985-17001	full-information	_
98-13	17002-17009	maximum	_
98-14	17010-17020	likelihood	_
98-15	17021-17031	estimation	_
98-16	17032-17034	to	_
98-17	17035-17038	use	_
98-18	17039-17042	all	_
98-19	17043-17047	data	_
98-20	17048-17057	available	_
98-21	17058-17059	.	_

99-1	17060-17062	As	_
99-2	17063-17065	an	_
99-3	17066-17076	additional	_
99-4	17077-17085	analysis	_
99-5	17086-17087	,	_
99-6	17088-17090	we	_
99-7	17091-17099	examined	_
99-8	17100-17103	the	_
99-9	17104-17114	hypothesis	_
99-10	17115-17119	that	_
99-11	17120-17126	higher	_
99-12	17127-17133	szPGRS	_
99-13	17134-17137	was	_
99-14	17138-17148	associated	_
99-15	17149-17153	with	_
99-16	17154-17155	a	_
99-17	17156-17163	steeper	_
99-18	17164-17171	decline	_
99-19	17172-17174	in	_
99-20	17175-17184	cognition	_
99-21	17185-17188	via	_
99-22	17189-17195	change	_
99-23	17196-17198	in	_
99-24	17199-17204	white	_
99-25	17205-17211	matter	_
99-26	17212-17221	structure	_
99-27	17222-17223	.	_

100-1	17224-17226	We	_
100-2	17227-17231	used	_
100-3	17232-17235	SEM	_
100-4	17236-17238	in	_
100-5	17239-17242	the	_
100-6	17243-17244	‘	_
100-7	17245-17251	lavaan	_
100-8	17252-17253	’	_
100-9	17254-17261	package	_
100-10	17262-17266	with	_
100-11	17267-17283	full-information	_
100-12	17284-17291	maximum	_
100-13	17292-17302	likelihood	_
100-14	17303-17313	estimation	_
100-15	17314-17316	to	_
100-16	17317-17324	derived	_
100-17	17325-17326	a	_
100-18	17327-17333	latent	_
100-19	17334-17339	score	_
100-20	17340-17342	of	_
100-21	17343-17350	general	_
100-22	17351-17356	fluid	_
100-23	17357-17369	intelligence	_
100-24	17370-17371	(	_
100-25	17372-17374	gf	_
100-26	17375-17376	)	_
100-27	17377-17380	for	_
100-28	17381-17385	each	_
100-29	17386-17390	wave	_
100-30	17391-17395	from	_
100-31	17396-17399	six	_
100-32	17400-17410	non-verbal	_
100-33	17411-17416	tests	_
100-34	17417-17419	of	_
100-35	17420-17429	cognitive	_
100-36	17430-17438	function	_
100-37	17439-17443	from	_
100-38	17444-17447	the	_
100-39	17448-17456	Weschler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
100-40	17457-17462	Adult	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
100-41	17463-17475	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
100-42	17476-17481	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
100-43	17482-17487	IIIUK	_
100-44	17488-17489	:	_
100-45	17490-17496	matrix	_
100-46	17497-17506	reasoning	_
100-47	17507-17508	(	_
100-48	17509-17519	non-verbal	_
100-49	17520-17529	reasoning	_
100-50	17530-17531	)	_
100-51	17532-17533	,	_
100-52	17534-17539	block	_
100-53	17540-17546	design	_
100-54	17547-17548	(	_
100-55	17549-17563	constructional	_
100-56	17564-17571	ability	_
100-57	17572-17573	)	_
100-58	17574-17575	,	_
100-59	17576-17582	symbol	_
100-60	17583-17589	search	_
100-61	17590-17593	and	_
100-62	17594-17599	digit	_
100-63	17600-17606	symbol	_
100-64	17607-17608	(	_
100-65	17609-17619	processing	_
100-66	17620-17625	speed	_
100-67	17626-17627	)	_
100-68	17628-17629	,	_
100-69	17630-17636	letter	_
100-70	17637-17643	number	_
100-71	17644-17654	sequencing	_
100-72	17655-17658	and	_
100-73	17659-17664	digit	_
100-74	17665-17669	span	_
100-75	17670-17679	backwards	_
100-76	17680-17681	(	_
100-77	17682-17689	working	_
100-78	17690-17696	memory	_
100-79	17697-17698	)	_
100-80	17699-17700	.	_

101-1	17701-17707	Within	_
101-2	17708-17711	the	_
101-3	17712-17717	model	_
101-4	17718-17719	,	_
101-5	17720-17724	each	_
101-6	17725-17734	cognitive	_
101-7	17735-17739	test	_
101-8	17740-17743	was	_
101-9	17744-17752	adjusted	_
101-10	17753-17756	for	_
101-11	17757-17760	age	_
101-12	17761-17763	in	_
101-13	17764-17768	days	_
101-14	17769-17771	at	_
101-15	17772-17775	the	_
101-16	17776-17780	time	_
101-17	17781-17783	of	_
101-18	17784-17794	assessment	_
101-19	17795-17798	and	_
101-20	17799-17802	sex	_
101-21	17803-17805	at	_
101-22	17806-17809	the	_
101-23	17810-17818	manifest	_
101-24	17819-17824	level	_
101-25	17825-17826	.	_

102-1	17827-17829	We	_
102-2	17830-17841	constrained	_
102-3	17842-17845	the	_
102-4	17846-17854	loadings	_
102-5	17855-17858	for	_
102-6	17859-17863	each	_
102-7	17864-17874	individual	_
102-8	17875-17878	raw	_
102-9	17879-17884	score	_
102-10	17885-17891	across	_
102-11	17892-17897	waves	_
102-12	17898-17899	(	_
102-13	17900-17903	i.e	_
102-14	17904-17905	.	_

103-1	17906-17911	equal	_
103-2	17912-17920	loadings	_
103-3	17921-17924	for	_
103-4	17925-17931	matrix	_
103-5	17932-17941	reasoning	_
103-6	17942-17944	at	_
103-7	17945-17953	baseline	_
103-8	17954-17957	and	_
103-9	17958-17967	follow-up	_
103-10	17968-17969	)	_
103-11	17970-17971	.	_

104-1	17972-17978	Beyond	_
104-2	17979-17982	the	_
104-3	17983-17991	analyses	_
104-4	17992-17994	of	_
104-5	17995-18001	szPGRS	_
104-6	18002-18004	to	_
104-7	18005-18008	the	_
104-8	18009-18017	mediator	_
104-9	18018-18019	(	_
104-10	18020-18021	A	_
104-11	18022-18026	path	_
104-12	18027-18028	)	_
104-13	18029-18030	,	_
104-14	18031-18033	to	_
104-15	18034-18038	test	_
104-16	18039-18046	whether	_
104-17	18047-18050	the	_
104-18	18051-18060	mediation	_
104-19	18061-18062	(	_
104-20	18063-18069	change	_
104-21	18070-18074	from	_
104-22	18075-18079	path	_
104-23	18080-18081	C	_
104-24	18082-18084	to	_
104-25	18085-18087	C′	_
104-26	18088-18089	)	_
104-27	18090-18093	was	_
104-28	18094-18107	statistically	_
104-29	18108-18119	significant	_
104-30	18120-18121	(	_
104-31	18122-18126	pFDR	_
104-32	18127-18128	<	_
104-33	18129-18133	0.05	_
104-34	18134-18135	)	_
104-35	18136-18137	,	_
104-36	18138-18140	we	_
104-37	18141-18147	tested	_
104-38	18148-18155	whether	_
104-39	18156-18159	the	_
104-40	18160-18166	direct	_
104-41	18167-18171	path	_
104-42	18172-18174	of	_
104-43	18175-18181	szPGRS	_
104-44	18182-18184	to	_
104-45	18185-18187	gf	_
104-46	18188-18189	(	_
104-47	18190-18194	path	_
104-48	18195-18196	C	_
104-49	18197-18198	)	_
104-50	18199-18202	and	_
104-51	18203-18206	the	_
104-52	18207-18215	indirect	_
104-53	18216-18220	path	_
104-54	18221-18225	from	_
104-55	18226-18229	the	_
104-56	18230-18238	mediator	_
104-57	18239-18241	to	_
104-58	18242-18244	gf	_
104-59	18245-18246	(	_
104-60	18247-18251	path	_
104-61	18252-18253	B	_
104-62	18254-18255	)	_
104-63	18256-18260	were	_
104-64	18261-18272	significant	_
104-65	18273-18274	.	_

105-1	18275-18278	Fig	_
105-2	18279-18280	.	_

106-1	18281-18282	2	_
106-2	18283-18288	shows	_
106-3	18289-18290	a	_
106-4	18291-18301	simplified	_
106-5	18302-18309	diagram	_
106-6	18310-18312	of	_
106-7	18313-18316	the	_
106-8	18317-18322	model	_
106-9	18323-18327	that	_
106-10	18328-18331	was	_
106-11	18332-18336	used	_
106-12	18337-18339	to	_
106-13	18340-18347	examine	_
106-14	18348-18352	this	_
106-15	18353-18363	hypothesis	_
106-16	18364-18365	.	_

107-1	18366-18369	All	_
107-2	18370-18382	significance	_
107-3	18383-18384	(	_
107-4	18385-18386	p	_
107-5	18387-18388	)	_
107-6	18389-18395	values	_
107-7	18396-18397	(	_
107-8	18398-18399	α	_
107-9	18400-18401	=	_
107-10	18402-18406	0.05	_
107-11	18407-18408	)	_
107-12	18409-18413	were	_
107-13	18414-18423	corrected	_
107-14	18424-18427	for	_
107-15	18428-18436	multiple	_
107-16	18437-18448	comparisons	_
107-17	18449-18454	using	_
107-18	18455-18460	false	_
107-19	18461-18470	discovery	_
107-20	18471-18475	rate	_
107-21	18476-18477	(	_
107-22	18478-18481	FDR	_
107-23	18482-18483	,	_
107-24	18484-18488	pFDR	_
107-25	18489-18490	)	_
107-26	18491-18492	.	_

